Human B-Species +
embryonic O +
stem O +
cells O +
( O -
hESCs O -
) O +
and O +
neural O +
progenitor O +
( O -
NP O -
) O +
cells O +
are O +
excellent O +
models O +
for O +
recapitulating O +
early O +
neuronal O +
development O +
in O +
vitro O -
, O +
and O +
are O +
key O +
to O +
establishing O +
strategies O +
for O +
the O +
treatment O +
of O +
degenerative O +
disorders O -
. O +

While O +
much O +
effort O +
had O +
been O +
undertaken O +
to O +
analyze O +
transcriptional O +
and O +
epigenetic O +
differences O +
during O +
the O +
transition O +
of O +
hESC O +
to O +
NP O -
, O +
very O +
little O +
work O +
has O +
been O +
performed O +
to O +
understand O +
post O -
- O -
transcriptional O +
changes O +
during O +
neuronal O +
differentiation O -
. O +

Alternative O +
RNA O +
splicing O +
( O -
AS O -
) O -
, O +
a O +
major O +
form O +
of O +
post O -
- O -
transcriptional O +
gene O +
regulation O -
, O +
is O +
important O +
in O +
mammalian O +
development O +
and O +
neuronal O +
function O -
. O +

Human B-Species +
ESC O -
, O +
hESC O -
- O -
derived O +
NP O -
, O +
and O +
human B-Species +
central O +
nervous O +
system O +
stem O +
cells O +
were O +
compared O +
using O +
Affymetrix O +
exon O +
arrays O -
. O +

We O +
introduced O +
an O +
outlier O +
detection O +
approach O -
, O +
REAP O +
( O -
Regression O -
- O -
based O +
Exon O +
Array O +
Protocol O -
) O -
, O +
to O +
identify O +
1,737 O +
internal O +
exons O +
that O +
are O +
predicted O +
to O +
undergo O +
AS O +
in O +
NP O +
compared O +
to O +
hESC O -
. O +

Experimental O +
validation O +
of O +
REAP O -
- O -
predicted O +
AS O +
events O +
indicated O +
a O +
threshold O -
- O -
dependent O +
sensitivity O +
ranging O +
from O +
56 O -
% O +
to O +
69 O -
% O -
, O +
at O +
a O +
specificity O +
of O +
77 O -
% O +
to O +
96 O -
% O -
. O +

REAP O +
predictions O +
significantly O +
overlapped O +
sets O +
of O +
alternative O +
events O +
identified O +
using O +
expressed O +
sequence O +
tags O +
and O +
evolutionarily O +
conserved O +
AS O +
events O -
. O +

Our O +
results O +
also O +
reveal O +
that O +
focusing O +
on O +
differentially O +
expressed O +
genes O +
between O +
hESC O +
and O +
NP O +
will O +
overlook O +
14 O -
% O +
of O +
potential O +
AS O +
genes O -
. O +

In O +
addition O -
, O +
we O +
found O +
that O +
REAP O +
predictions O +
are O +
enriched O +
in O +
genes O +
encoding O +
serine O -
/ O -
threonine O +
kinase O +
and O +
helicase O +
activities O -
. O +

An O +
example O +
is O +
a O +
REAP O -
- O -
predicted O +
alternative O +
exon O +
in O +
the O +
SLK O +
( O -
serine O -
/ O -
threonine O +
kinase O +
2 O -
) O +
gene O +
that O +
is O +
differentially O +
included O +
in O +
hESC O -
, O +
but O +
skipped O +
in O +
NP O +
as O +
well O +
as O +
in O +
other O +
differentiated O +
tissues O -
. O +

Lastly O -
, O +
comparative O +
sequence O +
analysis O +
revealed O +
conserved O +
intronic O +
cis O -
- O -
regulatory O +
elements O +
such O +
as O +
the O +
FOX1 O -
/ O -
2 O +
binding O +
site O +
GCAUG O +
as O +
being O +
proximal O +
to O +
candidate O +
AS O +
exons O -
, O +
suggesting O +
that O +
FOX1 O -
/ O -
2 O +
may O +
participate O +
in O +
the O +
regulation O +
of O +
AS O +
in O +
NP O +
and O +
hESC O -
. O +

In O +
summary O -
, O +
a O +
new O +
methodology O +
for O +
exon O +
array O +
analysis O +
was O +
introduced O -
, O +
leading O +
to O +
new O +
insights O +
into O +
the O +
complexity O +
of O +
AS O +
in O +
human B-Species +
embryonic O +
stem O +
cells O +
and O +
their O +
transition O +
to O +
neural O +
stem O +
cells O -
. O +

Author O +
SummaryDeriving O +
neural O +
progenitors O +
( O -
NP O -
) O +
from O +
human B-Species +
embryonic O +
stem O +
cells O +
( O -
hESC O -
) O +
is O +
the O +
first O +
step O +
in O +
creating O +
homogeneous O +
populations O +
of O +
cells O +
that O +
will O +
differentiate O +
into O +
myriad O +
neuronal O +
subtypes O +
necessary O +
to O +
form O +
a O +
human B-Species +
brain O -
. O +

During O +
alternative O +
RNA O +
splicing O +
( O -
AS O -
) O -
, O +
noncoding O +
sequences O +
( O -
introns O -
) O +
in O +
a O +
pre O -
- O -
mRNA O +
are O +
differentially O +
removed O +
in O +
different O +
cell O +
types O +
and O +
tissues O -
, O +
and O +
the O +
remaining O +
sequences O +
( O -
exons O -
) O +
are O +
joined O +
to O +
form O +
multiple O +
forms O +
of O +
mature O +
RNA O -
, O +
playing O +
an O +
important O +
role O +
in O +
cellular O +
diversity O -
. O +

The O +
authors O +
utilized O +
Affymetrix O +
exon O +
arrays O +
with O +
probes O +
targeting O +
hundreds O +
of O +
thousands O +
of O +
exons O +
to O +
study O +
AS O +
comparing O +
human B-Species +
ES O +
to O +
NP O -
. O +

To O +
accomplish O +
this O -
, O +
a O +
novel O +
computational O +
method O -
, O +
REAP O +
( O -
Regression O -
- O -
based O +
Exon O +
Array O +
Protocol O -
) O -
, O +
is O +
introduced O +
to O +
analyze O +
the O +
exon O +
array O +
data O -
. O +

The O +
authors O +
showed O +
that O +
REAP O +
candidates O +
are O +
consistent O +
with O +
other O +
types O +
of O +
methods O +
for O +
discovering O +
alternative O +
exons O -
. O +

In O +
addition O -
, O +
REAP O +
candidate O +
alternative O +
exons O +
are O +
enriched O +
in O +
genes O +
encoding O +
serine O -
/ O -
theronine O +
kinases O +
and O +
helicase O +
activities O -
. O +

An O +
example O +
is O +
the O +
alternative O +
exon O +
in O +
the O +
SLK O +
( O -
serine O -
/ O -
threonine O +
kinase O +
2 O -
) O +
gene O +
that O +
is O +
included O +
in O +
hESC O -
, O +
but O +
excluded O +
in O +
NP O +
as O +
well O +
as O +
in O +
other O +
differentiated O +
tissues O -
. O +

Finally O -
, O +
by O +
comparing O +
genomic O +
sequences O +
across O +
multiple O +
mammals O -
, O +
the O +
authors O +
identified O +
dozens O +
of O +
conserved O +
candidate O +
binding O +
sites O +
that O +
were O +
enriched O +
proximal O +
to O +
REAP O +
candidate O +
exons O -
. O +

The O +
human B-Species +
central O +
nervous O +
system O +
is O +
composed O +
of O +
thousands O +
of O +
neuronal O +
subtypes O +
originating O +
from O +
neural O +
stem O +
cells O +
( O -
NSCs O -
) O +
that O +
migrate O +
from O +
the O +
developing O +
neural O +
tube O -
. O +

Such O +
neuronal O +
complexity O +
is O +
generated O +
by O +
a O +
vast O +
repertoire O +
of O +
molecular O -
, O +
genetic O -
, O +
and O +
epigenetic O +
mechanisms O -
, O +
such O +
as O +
the O +
active O +
retrotransposition O +
of O +
transposable O +
elements O +
[ O -
1 O -
] O -
, O +
alternative O +
promoter O +
usage O -
, O +
alternative O +
RNA O +
splicing O +
( O -
AS O -
) O -
, O +
alternative O +
polyadenylation O -
, O +
RNA O +
editing O -
, O +
post O -
- O -
translational O +
modifications O -
, O +
and O +
epigenetic O +
modulation O +
[ O -
2 O -
] O -
. O +

Understanding O +
the O +
processes O +
that O +
generate O +
neuronal O +
diversity O +
is O +
key O +
to O +
gaining O +
insights O +
into O +
neuronal O +
development O +
and O +
paving O +
new O +
avenues O +
for O +
biomedical O +
research O -
. O +

Human B-Species +
embryonic O +
stem O +
cells O +
( O -
hESCs O -
) O +
are O +
pluripotent O +
cells O +
that O +
propagate O +
perpetually O +
in O +
culture O +
as O +
undifferentiated O +
cells O +
and O +
can O +
be O +
induced O +
to O +
differentiate O +
into O +
a O +
multitude O +
of O +
cell O +
types O +
both O +
in O +
vitro O +
and O +
in O +
vivo O +
[ O -
3 O -
] O -
. O +

As O +
hESCs O +
can O +
theoretically O +
generate O +
all O +
cell O +
types O +
that O +
make O +
up O +
an O +
organism O -
, O +
they O +
serve O +
as O +
an O +
important O +
model O +
for O +
understanding O +
early O +
human B-Species +
embryonic O +
development O -
. O +

In O +
addition O -
, O +
the O +
hESCs O +
are O +
a O +
nearly O +
infinite O +
source O +
for O +
generating O +
specialized O +
cells O +
such O +
as O +
neurons O +
and O +
glia O +
for O +
potential O +
therapeutic O +
purposes O +
[ O -
4,5 O -
] O -
. O +

In O +
recent O +
years O -
, O +
methods O +
have O +
been O +
introduced O +
to O +
induce O +
hESCs O +
to O +
differentiate O +
into O +
neural O +
progenitors O +
( O -
NPs O -
) O +
[ O -
6,7 O -
] O +
and O +
neuronal O +
and O +
glial O +
subtypes O +
[ O -
8–12 O -
] O -
. O +

The O +
therapeutic O +
interest O +
in O +
understanding O +
the O +
molecular O +
basis O +
of O +
pluripotency O +
and O +
differentiation O +
has O +
led O +
to O +
many O +
studies O +
comparing O +
transcriptional O +
profiles O +
in O +
different O +
hESC O +
lines O +
and O +
the O +
study O +
of O +
expression O +
changes O +
during O +
the O +
differentiation O +
of O +
hESCs O +
to O +
various O +
lineages O +
[ O -
13–17 O -
] O -
. O +

NSCs O +
and O +
progenitor O +
cells O +
( O -
NPs O -
) O +
are O +
present O +
throughout O +
development O +
and O +
persist O +
into O +
adulthood O +
[ O -
18–20 O -
] O -
. O +

They O +
are O +
critical O +
for O +
both O +
basic O +
research O +
and O +
developing O +
approaches O +
to O +
treat O +
neurological O +
disorders O -
, O +
such O +
as O +
Parkinson O +
disease O +
and O +
amyotrophic O +
lateral O +
sclerosis O +
( O -
ALS O -
) O -
, O +
and O +
stroke O +
or O +
head O +
injuries O +
[ O -
21,22 O -
] O -
. O +

NSCs O +
and O +
NPCs O +
can O +
be O +
isolated O +
from O +
human B-Species +
fetal O +
brain O +
tissue O +
[ O -
23–26 O -
] O -
, O +
as O +
well O +
as O +
from O +
several O +
regions O +
of O +
the O +
adult O +
human B-Species +
brain O -
, O +
such O +
as O +
the O +
cortex O -
, O +
hippocampus O -
, O +
and O +
the O +
subventricular O +
zone O +
( O -
SVZ O -
) O +
of O +
the O +
lateral O +
ventricles O +
[ O -
26–35 O -
] O -
. O +

Several O +
studies O +
have O +
explored O +
expression O +
patterns O +
of O +
NPCs O -
. O +

For O +
example O -
, O +
Wright O +
et O +
al. O +
identified O +
" O -
expressed O -
" O +
and O +
" O -
not O +
expressed O -
" O +
genes O +
in O +
NPCs O +
isolated O +
from O +
the O +
human B-Species +
embryonic O +
cortex O +
[ O -
24 O -
] O -
; O +
Cai O +
et O +
al. O +
used O +
the O +
massively O +
parallel O +
signature O +
sequencing O +
profiling O +
( O -
MPSS O -
) O +
technique O +
to O +
analyze O +
expression O +
of O +
fetal O +
NPCs O +
in O +
comparison O +
to O +
hESCs O +
and O +
astrocyte O +
precursors O +
[ O -
27 O -
] O -
; O +
Maisel O +
et O +
al. O +
used O +
Affymetrix O +
Gene O +
Chip O +
arrays O +
to O +
compare O +
adult O +
and O +
fetal O +
NPCs O +
propagated O +
in O +
neurospheres O +
[ O -
35 O -
] O -
. O +

However O -
, O +
as O +
with O +
hESCs O -
, O +
the O +
focus O +
thus O +
far O +
has O +
been O +
primarily O +
on O +
transcriptional O +
differences O -
, O +
which O +
ignores O +
differential O +
RNA O +
processing O +
such O +
as O +
AS O -
, O +
polyadenylation O -
, O +
degradation O -
, O +
or O +
promoter O +
usage O -
. O +

AS O +
is O +
frequently O +
used O +
to O +
regulate O +
gene O +
expression O +
and O +
to O +
generate O +
tissue O -
- O -
specific O +
mRNA O +
and O +
protein O +
isoforms O +
[ O -
36–39 O -
] O -
. O +

Recent O +
studies O +
using O +
splicing O -
- O -
sensitive O +
microarrays O +
suggested O +
that O +
up O +
to O +
75 O -
% O +
of O +
human B-Species +
genes O +
undergo O +
AS O -
, O +
where O +
multiple O +
isoforms O +
are O +
derived O +
from O +
the O +
same O +
genetic O +
loci O +
[ O -
40 O -
] O -
. O +

This O +
functional O +
complexity O +
underscores O +
the O +
challenge O +
and O +
importance O +
of O +
elucidating O +
AS O +
regulation O -
. O +

AS O +
appears O +
to O +
play O +
a O +
dominant O +
role O +
in O +
regulating O +
neuronal O +
gene O +
expression O +
and O +
function O +
[ O -
41,42 O -
] O -
. O +

Examples O +
of O +
splicing O +
regulators O +
that O +
are O +
enriched O +
and O +
function O +
specifically O +
in O +
neuronal O +
cells O +
include O +
the O +
brain O -
- O -
specific O +
splicing O +
factor O +
Nova O +
[ O -
43,44 O -
] O +
and O +
neural O -
- O -
specific O +
polypyrimidine O +
tract O +
binding O +
protein O +
( O -
nPTB O -
) O -
, O +
which O +
antagonizes O +
its O +
paralogous O +
PTB O +
to O +
regulate O +
exon O +
exclusion O +
in O +
neuronal O +
cells O +
[ O -
45–47 O -
] O -
. O +

Finally O -
, O +
an O +
early O +
report O +
estimating O +
that O +
15 O -
% O +
of O +
point O +
mutations O +
disrupt O +
splicing O +
underscores O +
the O +
importance O +
of O +
splicing O +
in O +
human B-Species +
disease O +
[ O -
48 O -
] O -
. O +

Indeed O -
, O +
the O +
disruption O +
of O +
specific O +
AS O +
events O +
has O +
been O +
implicated O +
in O +
several O +
human B-Species +
genetic O +
diseases O -
, O +
such O +
as O +
frontotemporal O +
dementia O +
and O +
parkinsonism O -
, O +
Frasier O +
syndrome O -
, O +
and O +
atypical O +
cystic O +
fibrosis O +
[ O -
49 O -
] O -
. O +

While O +
insights O +
into O +
the O +
regulation O +
of O +
AS O +
have O +
come O +
predominantly O +
from O +
the O +
molecular O +
dissection O +
of O +
individual O +
genes O +
[ O -
36,49 O -
] O -
, O +
it O +
is O +
becoming O +
clear O +
that O +
molecular O +
rules O +
can O +
be O +
identified O +
from O +
large O -
- O -
scale O +
studies O +
of O +
both O +
constitutive O +
splicing O +
and O +
AS O +
[ O -
40 O -
] O -
. O +

Most O +
systematic O +
global O +
analyses O +
on O +
AS O +
have O +
focused O +
on O +
comparisons O +
across O +
differentiated O +
human B-Species +
tissues O +
[ O -
50–52 O -
] O -
. O +

Only O +
one O +
study O -
, O +
utilizing O +
expressed O +
sequence O +
tag O +
( O -
EST O -
) O +
collections O +
from O +
stem O +
cells O -
, O +
has O +
attempted O +
to O +
find O +
AS O +
differences O +
between O +
embryonic O +
and O +
hematopoietic O +
stem O +
cells O +
[ O -
53 O -
] O -
. O +

However O -
, O +
utilizing O +
ESTs O +
to O +
identify O +
AS O +
has O +
intrinsic O +
problems O -
, O +
as O +
ESTs O +
tend O +
to O +
be O +
biased O +
for O +
the O +
3′ O +
ends O +
of O +
genes O -
, O +
and O +
full O +
coverage O +
of O +
the O +
genome O +
by O +
ESTs O +
is O +
severely O +
limited O +
by O +
sequencing O +
costs O -
. O +

The O +
commercial O +
availability O +
of O +
Affymetrix O +
exon O +
arrays O +
provides O +
an O +
alternative O +
approach O +
to O +
interrogate O +
the O +
expression O +
of O +
every O +
known O +
and O +
predicted O +
exon O +
in O +
the O +
human B-Species +
genome O -
. O +

The O +
Affymetrix O +
GeneChip O +
Human O +
Exon O +
1.0 O +
ST O +
array O +
contains O +
∼5.4 O +
million O +
features O +
used O +
to O +
interrogate O +
∼1 O +
million O +
exon O +
clusters O +
( O -
collections O +
of O +
overlapping O -
) O +
of O +
known O +
and O +
predicted O +
exons O +
with O +
more O +
than O +
1.4 O +
million O +
probesets O -
, O +
with O +
an O +
average O +
of O +
four O +
probes O +
per O +
exon O -
. O +

Our O +
goal O +
was O +
to O +
identify O +
and O +
characterize O +
AS O +
events O +
that O +
distinguish O +
pluripotent O +
hESCs O +
from O +
multipotent O +
NPs O -
, O +
paving O +
the O +
way O +
for O +
future O +
candidate O +
gene O +
approaches O +
to O +
study O +
the O +
impact O +
of O +
AS O +
in O +
hESCs O +
and O +
NPs O -
. O +

However O -
, O +
as O +
different O +
hESC O +
lines O +
were O +
established O +
under O +
different O +
culture O +
conditions O +
from O +
embryos O +
with O +
unique O +
genetic O +
backgrounds O -
, O +
we O +
expected O +
that O +
hESCs O +
and O +
their O +
derived O +
NPs O +
might O +
have O +
distinct O +
epigenetic O +
and O +
molecular O +
signatures O +
[ O -
54 O -
] O -
. O +

As O +
both O +
common O +
and O +
cell O -
- O -
line O +
specific O +
alternatively O +
spliced O +
exons O +
are O +
likely O +
to O +
be O +
important O +
in O +
regenerative O +
research O -
, O +
in O +
our O +
study O +
two O +
separate O +
hESC O +
lines O +
were O +
used O -
, O +
with O +
independent O +
protocols O +
for O +
differentiating O +
the O +
hESCs O +
into O +
NPs O +
positive O +
for O +
Sox1 O -
, O +
an O +
early O +
neuroectodermal O +
marker O -
. O +

As O +
an O +
endogenously O +
occurring O +
population O +
of O +
NPs O -
, O +
human B-Species +
central O +
nervous O +
system O +
stem O +
cells O +
grown O +
as O +
neurospheres O +
( O -
hCNS O -
- O -
SCns O -
) O +
were O +
utilized O +
as O +
a O +
natural O +
benchmark O +
for O +
derived O +
NPs O -
. O +

We O +
developed O +
an O +
approach O +
called O +
REAP O +
( O -
Regression O -
- O -
based O +
Exon O +
Array O +
Protocol O -
) O -
, O +
which O +
is O +
based O +
on O +
robust O +
regression O +
that O +
analyzed O +
signal O +
estimates O +
from O +
Affymetrix O +
exon O +
array O +
data O +
to O +
identify O +
AS O +
exons O -
. O +

Experimental O +
validation O +
revealed O +
alternative O +
exons O +
that O +
distinguish O +
hESCs O +
from O +
NPs O -
; O +
some O +
of O +
them O +
also O +
distinguish O +
hESCs O +
from O +
a O +
variety O +
of O +
differentiated O +
tissues O -
. O +

A O +
comparison O +
of O +
REAP O -
- O -
predicted O +
alternative O +
events O +
with O +
independent O +
methods O -
, O +
such O +
as O +
using O +
publicly O +
available O +
transcripts O +
( O -
ESTs O +
and O +
mRNAs O -
) O +
and O +
computational O +
predictions O +
based O +
on O +
genomic O +
sequence O +
information O +
alone O +
[ O -
55 O -
] O -
, O +
showed O +
a O +
strong O +
concordance O +
of O +
REAP O -
- O -
identified O +
AS O +
exons O +
with O +
AS O +
events O +
identified O +
from O +
these O +
orthogonal O +
methods O -
. O +

Finally O -
, O +
using O +
analysis O +
of O +
the O +
sequences O +
flanking O +
REAP O -
- O -
identified O +
alternative O +
exons O -
, O +
we O +
were O +
able O +
to O +
discover O +
known O +
and O +
novel O +
cis O -
- O -
regulatory O +
elements O +
that O +
potentially O +
regulate O +
these O +
AS O +
events O -
. O +

Derivation O +
of O +
Neural O +
Progenitors O +
from O +
Embryonic O +
Stem O +
CellsNPs O +
were O +
independently O +
derived O +
from O +
two O +
hESC O +
lines O -
, O +
and O +
RNA O +
extracted O +
from O +
the O +
cell O +
lines O +
was O +
processed O +
and O +
hybridized O +
onto O +
Affymetrix O +
Human B-Species +
1.0 O +
ST O +
exon O +
arrays O -
. O +

Immunohistochemical O +
and O +
reverse O -
- O -
transcriptase O +
polymerase O +
chain O +
reaction O +
( O -
RT O -
- O -
PCR O -
) O +
analyses O +
demonstrated O +
that O +
the O +
hESCs O +
expressed O +
pluripotent O +
marker O +
genes O -
, O +
and O +
the O +
derived O +
NPs O +
expressed O +
multipotent O +
and O +
neurogenic O +
markers O +
similar O +
to O +
hCNS O -
- O -
SCns O -
. O +

Undifferentiated O +
Cythera O +
( O -
Cyt O -
- O -
ES O -
) O +
and O +
HUES6 O +
( O -
HUES6-ES O -
) O +
hESC O +
lines O +
were O +
maintained O +
in O +
culture O +
as O +
previously O +
described O +
[ O -
12,23,56 O -
] O -
. O +

Utilizing O +
specific O +
antibodies O -
, O +
we O +
observed O +
that O +
undifferentiated O +
Cyt O -
- O -
ES O +
and O +
HUES6-ES O +
cells O +
were O +
positive O +
for O +
the O +
pluripotent O +
markers O +
Oct4 O -
, O +
SSEA-4 O -
, O +
and O +
Tra-1–80 O +
( O -
unpublished O +
data O -
) O -
. O +

NPs O +
were O +
derived O +
from O +
the O +
hESC O +
cell O +
lines O +
using O +
protocols O +
optimized O +
for O +
each O +
line O +
( O -
see O +
Materials O +
and O +
Methods O -
) O -
. O +

Greater O +
than O +
90 O -
% O +
of O +
derived O +
NP O +
cells O +
( O -
Cyt O -
- O -
NP O +
from O +
Cyt O -
- O -
ES O +
and O +
HUES6-NP O +
from O +
HUES6-ES O -
) O +
were O +
positive O +
for O +
Sox1 O -
, O +
an O +
early O +
neuroectodermal O +
marker O -
, O +
and O +
Nestin O +
( O -
Figure O +
1A O -
) O -
, O +
and O +
negative O +
for O +
Oct4 O +
( O -
unpublished O +
data O -
) O -
. O +

As O +
a O +
natural O +
benchmark O +
for O +
the O +
derived O +
NPs O -
, O +
we O +
utilized O +
hCNS O -
- O -
SCns O -
, O +
which O +
were O +
previously O +
isolated O +
from O +
fresh O +
human B-Species +
fetal O +
brain O +
tissues O +
using O +
antibodies O +
to O +
cell O -
- O -
surface O +
markers O +
and O +
fluorescence O -
- O -
activated O +
cell O +
sorting O +
[ O -
12,23 O -
] O -
. O +

The O +
hCNS O -
- O -
SCns O +
form O +
neurospheres O +
in O +
culture O +
which O +
are O +
greater O +
than O +
90 O -
% O +
Nestin O +
and O +
Sox1 O +
positive O -
, O +
and O +
differentiate O +
into O +
both O +
neurons O +
and O +
glial O +
cells O +
in O +
vitro O +
[ O -
12,23 O -
] O -
. O +

Immunohistochemical O +
analysis O +
confirmed O +
that O +
hCNS O -
- O -
SCns O +
were O +
negative O +
for O +
Oct4 O +
( O -
unpublished O +
data O -
) O +
and O +
positive O +
for O +
Sox1 O +
and O +
Nestin O +
( O -
Figure O +
1A O -
) O -
.Figure O +
1Molecular O +
Characterization O +
of O +
Human B-Species +
Embryonic O +
Stem O +
Cell O +
Lines O +
and O +
Neuronal O +
Progenitors O -
( O -
A O -
) O +
Immunohistochemical O +
analysis O +
of O +
markers O +
in O +
NPs O +
derived O +
from O +
the O +
hESC O +
lines O +
( O -
Cyt O -
- O -
NP O +
from O +
Cyt O -
- O -
ES O -
; O +
and O +
HUES6-NP O +
from O +
HUES6-ES O -
) O +
and O +
in O +
hCNS O -
- O -
SCns O -
. O +

Cyt O -
- O -
NP O -
, O +
HUES6-NP O -
, O +
and O +
hCNS O -
- O -
SCns O +
cells O +
were O +
Nestin O +
and O +
Sox1 O +
positive O -
. O +

Nuclei O +
stained O +
positive O +
for O +
Dapi O -
. O +

White O +
horizontal O +
bar O +
indicated O +
15 O +
μm. O -
( O -
B O -
) O +
Gene O -
- O -
level O +
signal O +
estimates O +
of O +
marker O +
genes O +
( O -
GAPDH O -
, O +
Oct4 O -
, O +
Nanog O -
, O +
Nestin O -
, O +
Notch1 O -
, O +
DNER O -
, O +
and O +
Sox1 O -
) O +
from O +
Affymetrix O +
exon O +
array O +
analysis O -
. O +

Vertical O +
bars O +
indicated O +
average O +
log2 O +
normalized O +
signal O +
estimates O -
, O +
and O +
error O +
bars O +
represented O +
standard O +
deviations O +
from O +
three O +
independent O +
replicate O +
experiments O +
per O +
cell O +
type. O -
( O -
C O -
) O +
RT O -
- O -
PCR O +
of O +
marker O +
genes O +
( O -
GAPDH O -
, O +
Oct4 O -
, O +
Nanog O -
, O +
Nestin O -
, O +
Notch1 O -
, O +
DNER O -
, O +
and O +
Sox1 O -
) O -
.Here O -
, O +
known O +
molecular O +
markers O +
were O +
subjected O +
to O +
RT O -
- O -
PCR O +
measurements O -
, O +
which O +
were O +
compared O +
to O +
gene O -
- O -
level O +
signal O +
estimates O +
generated O +
from O +
the O +
exon O +
array O +
data O -
. O +

Total O +
RNA O +
was O +
extracted O -
, O +
and O +
labeled O +
cDNA O +
targets O +
were O +
generated O +
from O +
three O +
independent O +
preparations O +
of O +
each O +
cell O +
type O -
, O +
namely O +
Cyt O -
- O -
ES O -
, O +
HUES6-ES O -
, O +
Cyt O -
- O -
NP O -
, O +
HUES6-NP O -
, O +
and O +
hCNS O -
- O -
SCns O -
. O +

To O +
facilitate O +
downstream O +
analyses O -
, O +
instead O +
of O +
utilizing O +
the O +
meta O -
- O -
gene O +
sets O +
available O +
from O +
the O +
manufacturers O -
, O +
we O +
generated O +
our O +
own O +
gene O +
models O +
by O +
clustering O +
alignments O +
of O +
ESTs O +
and O +
mRNAs O +
to O +
annotated O +
known O +
genes O +
from O +
the O +
University O +
of O +
California O +
Santa O +
Cruz O +
( O -
UCSC O -
) O +
Genome O +
Browser O +
Database O -
. O +

After O +
hybridization O -
, O +
scanning O -
, O +
and O +
extraction O +
of O +
signal O +
estimates O +
for O +
each O +
probeset O +
on O +
the O +
exon O +
arrays O -
, O +
gene O -
- O -
level O +
estimates O +
were O +
computed O +
based O +
on O +
our O +
gene O +
models O +
using O +
available O +
normalization O +
and O +
signal O +
estimation O +
software O +
from O +
Affymetrix O -
. O +

For O +
every O +
gene O -
, O +
a O +
t O -
- O -
statistic O +
and O +
corresponding O +
p O -
- O -
value O +
were O +
computed O +
representing O +
the O +
relative O +
enrichment O +
of O +
the O +
expression O +
of O +
the O +
gene O +
in O +
hESC O +
versus O +
NP O -
, O +
such O +
as O +
in O +
Cyt O -
- O -
ES O +
versus O +
Cyt O -
- O -
NP O -
. O +

After O +
correcting O +
for O +
multiple O +
hypothesis O +
testing O +
using O +
the O +
Benjamini O -
- O -
Hochberg O +
method O -
, O +
a O +
p O -
- O -
value O +
cutoff O +
of O +
0.01 O +
was O +
used O +
to O +
identify O +
enriched O +
genes O -
. O +

Close O +
inspection O +
of O +
all O +
pairs O +
of O +
hESC O -
- O -
NP O +
comparisons O +
revealed O +
a O +
generally O +
significant O +
overlap O +
from O +
31 O -
% O +
to O +
85 O -
% O +
of O +
the O +
smaller O +
of O +
two O +
compared O +
sets O +
of O +
enriched O +
genes O +
( O -
see O +
Figure O +
S1 O -
) O -
. O +

Thus O +
for O +
the O +
purpose O +
of O +
identifying O +
overall O +
pluripotent O +
and O +
neural O +
lineage O -
- O -
specific O +
genes O -
, O +
the O +
collective O +
set O +
of O +
NPs O +
( O -
Cyt O -
- O -
NP O -
, O +
HUES6-NP O -
, O +
and O +
hCNS O -
- O -
SCns O -
) O +
was O +
compared O +
to O +
the O +
collective O +
set O +
of O +
hESCs O +
( O -
Cyt O -
- O -
ES O +
and O +
HUES6-ES O -
) O -
.Oct4 O +
and O +
Nanog O -
, O +
which O +
are O +
important O +
in O +
maintaining O +
the O +
pluripotent O +
state O +
of O +
embryonic O +
stem O +
cells O +
( O -
ESCs O -
) O -
, O +
were O +
highly O +
expressed O +
in O +
hESCs O +
but O +
were O +
significantly O +
lower O +
in O +
NPs O +
( O -
Figure O +
1B O -
) O -
. O +

RT O -
- O -
PCR O +
of O +
Oct4 O +
and O +
Nanog O +
mRNA O +
levels O +
accurately O +
reflected O +
the O +
signal O +
estimates O +
from O +
the O +
array O +
( O -
Figure O +
1C O -
) O -
. O +

Interestingly O -
, O +
Nestin O +
was O +
not O +
significantly O +
higher O +
in O +
NPs O +
as O +
compared O +
to O +
the O +
hESC O +
from O +
the O +
gene O -
- O -
level O +
estimates O +
( O -
p O -
- O -
value O +
0.065 O -
) O -
, O +
which O +
was O +
further O +
confirmed O +
by O +
RT O -
- O -
PCR O +
( O -
Figure O +
1C O -
) O -
. O +

Notch O +
was O +
recently O +
identified O +
to O +
be O +
important O +
in O +
promoting O +
the O +
neural O +
lineage O +
entry O +
in O +
mouse B-Species +
ESCs O +
[ O -
57 O -
] O +
and O +
was O +
shown O +
to O +
regulate O +
stem O +
cell O +
proliferation O +
in O +
somatic O +
mouse B-Species +
and O +
hESC O +
[ O -
58 O -
] O -
. O +

Gene O -
- O -
level O +
signal O +
estimates O +
suggested O +
that O +
Notch O +
was O +
significantly O +
higher O +
in O +
hCNS O -
- O -
SCns O +
relative O +
to O +
hESCs O -
, O +
but O +
levels O +
of O +
Notch O +
were O +
not O +
significantly O +
different O +
in O +
the O +
derived O +
NPs O +
compared O +
to O +
hESCs O -
. O +

Delta O -
/ O -
Notch O -
- O -
like O +
EGF O -
- O -
related O +
receptor O +
( O -
DNER O -
) O -
, O +
a O +
neuron O -
- O -
specific O +
transmembrane O +
protein O -
, O +
was O +
recently O +
shown O +
to O +
bind O +
to O +
Notch O +
at O +
cell O -
– O -
cell O +
contacts O +
and O +
activates O +
Notch O +
signaling O +
in O +
vitro O +
[ O -
59 O -
] O -
. O +

RT O -
- O -
PCR O +
validation O +
of O +
DNER O +
confirmed O +
array O -
- O -
derived O +
signal O +
estimates O -
, O +
indicating O +
an O +
enrichment O +
of O +
DNER O +
in O +
NPs O +
relative O +
to O +
hESCs O +
( O -
Figure O +
1C O -
) O -
. O +

Finally O -
, O +
Sox1 O -
, O +
a O +
HMG O -
- O -
box O +
protein O +
related O +
to O +
SRY O -
, O +
was O +
shown O +
to O +
be O +
one O +
of O +
the O +
earliest O +
transcription O +
factors O +
expressed O +
in O +
cells O +
committed O +
to O +
the O +
neural O +
fate O +
[ O -
60 O -
] O -
. O +

Here O +
the O +
gene O -
- O -
level O +
estimates O +
indicated O +
that O +
Sox1 O +
was O +
expressed O +
significantly O +
higher O +
in O +
NPs O +
relative O +
to O +
hESCs O +
( O -
p O -
- O -
value O +
0.00013 O -
, O +
Figure O +
1B O -
) O -
, O +
a O +
finding O +
that O +
was O +
confirmed O +
by O +
RT O -
- O -
PCR O +
( O -
Figure O +
1C O -
) O -
.From O +
these O +
examples O -
, O +
we O +
concluded O +
that O +
RT O -
- O -
PCR O +
validation O +
correlated O +
well O +
with O +
gene O -
- O -
level O +
estimates O +
from O +
the O +
exon O +
array O -
. O +

In O +
addition O -
, O +
the O +
derived O +
NPs O +
had O +
decreased O +
levels O +
of O +
pluripotent O +
markers O +
Oct4 O +
and O +
Nanog O +
but O +
had O +
levels O +
of O +
Sox1 O +
that O +
were O +
comparable O +
to O +
hCNS O -
- O -
SCns O -
. O +

This O +
finding O +
confirmed O +
that O +
the O +
derived O +
NPs O +
were O +
committed O +
to O +
a O +
neural O +
fate O +
and O +
validated O +
the O +
use O +
of O +
hCNS O -
- O -
SCns O +
as O +
a O +
benchmark O +
for O +
NPs O -
. O +

Next O +
we O +
asked O +
whether O +
the O +
highest O +
enriched O +
genes O +
in O +
hESCs O +
relative O +
to O +
NPs O +
reflected O +
our O +
existing O +
knowledge O +
in O +
the O +
literature O -
. O +

Using O +
the O +
above O -
- O -
mentioned O +
groupings O +
of O +
hESCs O +
( O -
Cyt O -
- O -
ES O -
, O +
HUES6-ES O -
) O +
and O +
NPs O +
( O -
Cyt O -
- O -
NP O -
, O +
HUES6-NP O -
, O +
and O +
hCNS O -
- O -
SCns O -
) O -
, O +
2,945 O +
genes O +
were O +
enriched O +
in O +
hESCs O +
relative O +
to O +
NPs O -
; O +
and O +
552 O +
genes O +
were O +
enriched O +
in O +
the O +
NPs O +
relative O +
to O +
hESCs O -
, O +
at O +
a O +
p O -
- O -
value O +
significance O +
cutoff O +
of O +
0.01 O +
( O -
correcting O +
for O +
multiple O +
hypothesis O +
testing O +
using O +
the O +
Benjamini O -
- O -
Hochberg O +
method O -
) O -
. O +

The O +
15 O +
most O +
enriched O +
genes O +
in O +
hESCs O +
included O +
genes O +
such O +
as O +
teratocarcinoma O -
- O -
derived O +
growth O +
factor O +
1 O +
( O -
TDGF1 O -
/ O -
cripto O -
; O +
p O -
- O -
value O +
< O +
10−12 O -
) O -
, O +
zinc O +
finger O +
protein O +
42 O +
( O -
Zfp42 O -
/ O -
Rex1 O -
; O +
p O -
- O -
value O +
< O +
10−12 O -
) O -
, O +
Oct4 O +
( O -
p O -
- O -
value O +
< O +
10−12 O -
) O -
, O +
Nanog O +
( O -
p O -
- O -
value O +
< O +
10−10 O -
) O -
, O +
lin-28 O +
homolog O +
( O -
p O -
- O -
value O +
< O +
10−10 O -
) O -
, O +
cadherin O +
1 O +
preprotein O +
( O -
p O -
- O -
value O +
< O +
10−10 O -
) O -
, O +
claudin O +
6 O +
( O -
p O -
- O -
value O +
< O +
10−9 O -
) O -
, O +
ephrin O +
receptor O +
EphA1 O +
( O -
p O -
- O -
value O +
< O +
10−9 O -
) O -
, O +
and O +
erbB3 O +
( O -
p O -
- O -
value O +
< O +
10−9 O -
) O -
. O +

TDGF1 O -
/ O -
cripto O +
was O +
first O +
shown O +
to O +
stimulate O +
DNA O +
synthesis O +
and O +
cell O +
proliferation O +
of O +
both O +
undifferentiated O +
and O +
differentiated O +
embryonic O +
carcinoma O +
cells O +
[ O -
61 O -
] O +
and O +
was O +
later O +
shown O +
to O +
be O +
important O +
for O +
cardiomyocyte O +
formation O +
from O +
mouse B-Species +
ESC O +
[ O -
62 O -
] O -
. O +

Oct4 O -
, O +
reviewed O +
in O +
[ O -
63 O -
] O -
, O +
and O +
Nanog O +
[ O -
64 O -
] O +
are O +
crucial O +
for O +
the O +
pluripotency O +
of O +
hESCs O -
. O +

Recently O -
, O +
knockdown O +
of O +
Zfp42 O -
/ O -
Rex-1 O +
in O +
mouse B-Species +
ESC O +
caused O +
the O +
cells O +
to O +
differentiate O +
[ O -
65 O -
] O -
. O +

Our O +
gene O -
- O -
level O +
exon O +
array O +
analysis O +
confirmed O +
that O +
the O +
hESCs O +
and O +
NPs O +
were O +
molecularly O +
distinct O -
. O +

To O +
reveal O +
global O +
functional O +
differences O +
between O +
the O +
enriched O +
genes O +
in O +
hESCs O +
or O +
NPs O -
, O +
the O +
enriched O +
genes O +
were O +
subjected O +
to O +
a O +
Gene O +
Ontology O +
( O -
GO O -
, O +
http://www.geneontology.org O -
) O +
analysis O +
as O +
described O +
previously O +
[ O -
55 O -
] O -
. O +

Enriched O +
genes O +
in O +
hESCs O +
were O +
more O +
likely O +
to O +
be O +
in O +
molecular O +
function O +
categories O -
, O +
such O +
as O +
" O -
RNA O +
binding O -
" O +
( O -
p O -
- O -
value O +
< O +
10−12 O -
) O -
, O +
" O -
structural O +
constituent O +
of O +
ribosome O -
" O +
( O -
p O -
- O -
value O +
< O +
10−51 O -
) O -
, O +
" O -
exonuclease O +
activity O -
" O +
( O -
p O -
- O -
value O +
< O +
10−6 O -
) O -
, O +
" O -
cytochrome O -
- O -
c O +
oxidase O +
activity O -
" O +
( O -
p O -
- O -
value O +
< O +
10−5 O -
) O -
, O +
and O +
" O -
ATP O +
binding O -
" O +
( O -
p O -
- O -
value O +
< O +
10−6 O -
) O -
, O +
and O +
in O +
biological O +
processes O +
involved O +
with O +
" O -
tRNA O +
processing O -
" O +
( O -
p O -
- O -
value O +
< O +
10−6 O -
) O +
and O +
" O -
protein O +
biosynthesis O -
" O +
( O -
p O -
- O -
value O +
< O +
10−48 O -
) O -
, O +
consistent O +
with O +
our O +
knowledge O +
of O +
hESCs O +
as O +
a O +
rapidly O +
proliferating O +
population O +
of O +
cells O +
( O -
Figure O +
2A O -
) O -
. O +

Similar O +
analysis O +
of O +
the O +
enriched O +
genes O +
in O +
NPs O +
revealed O +
an O +
overrepresentation O +
in O +
molecular O +
functional O +
categories O -
, O +
such O +
as O +
" O -
calcium O +
ion O +
binding O -
" O +
( O -
p O -
- O -
value O +
< O +
10−8 O -
) O +
and O +
" O -
structural O +
molecule O +
activity O -
" O +
( O -
p O -
- O -
value O +
< O +
10−5 O -
) O -
, O +
and O +
in O +
biological O +
processes O +
involved O +
with O +
" O -
neurogenesis O -
" O +
( O -
p O -
- O -
value O +
< O +
10−38 O -
) O -
, O +
" O -
cell O +
adhesion O -
" O +
( O -
p O -
- O -
value O +
< O +
10−13 O -
) O -
, O +
" O -
cell O +
motility O -
" O +
( O -
p O -
- O -
value O +
< O +
10−4 O -
) O -
, O +
" O -
development O -
" O +
( O -
p O -
- O -
value O +
< O +
10−6 O -
) O -
, O +
" O -
neuropeptide O +
signaling O +
pathway O -
" O +
( O -
p O -
- O -
value O +
< O +
10−4 O -
) O -
, O +
and O +
" O -
endocytosis O -
" O +
( O -
p O -
- O -
value O +
< O +
10−4 O -
) O +
( O -
Figure O +
2B O -
) O -
. O +

Considering O +
that O +
these O +
were O +
the O +
only O +
categories O +
that O +
were O +
significantly O +
enriched O +
out O +
of O +
more O +
than O +
18,000 O +
GO O +
terms O -
, O +
and O +
that O +
randomly O +
selected O +
sets O +
of O +
similar O +
numbers O +
of O +
genes O +
did O +
not O +
reveal O +
statistical O +
differences O +
in O +
GO O +
categories O -
, O +
our O +
results O +
confirmed O +
that O +
the O +
global O +
molecular O +
profiles O +
derived O +
from O +
exon O +
array O +
analysis O +
were O +
consistent O +
with O +
known O +
differences O +
between O +
hESCs O +
and O +
NPs O -
. O +

Figure O +
2Gene O +
Ontology O +
AnalysisDifferential O +
gene O +
expression O +
of O +
hESCs O +
( O -
Cyt O -
- O -
ES O +
and O +
HUES6-ES O -
) O +
and O +
NPs O +
( O -
Cyt O -
- O -
NP O -
, O +
HUES6-NP O -
, O +
and O +
hCNS O -
- O -
SCns O -
) O +
was O +
computed O +
from O +
gene O -
- O -
level O +
signal O +
estimates O -
. O +

Statistical O +
significance O +
for O +
differential O +
gene O +
expression O +
was O +
determined O +
by O +
using O +
t O -
- O -
statistics O +
with O +
Benjamini O -
- O -
Hochberg O +
correction O +
for O +
false O +
discovery O +
rate O +
( O -
p O +
< O +
0.01 O -
) O -
. O +

Gene O +
Ontology O +
" O -
molecular O +
function O -
, O -
" O +
" O -
cellular O +
component O -
, O -
" O +
and O +
" O -
biological O +
process O -
" O +
categories O -
, O +
which O +
differed O +
significantly O +
( O -
p O +
< O +
0.05 O -
) O +
in O +
the O +
representation O +
between O +
significantly O +
enriched O +
genes O +
( O -
black O +
bars O -
) O +
and O +
all O +
other O +
genes O +
( O -
white O +
bars O -
) O -
, O +
were O +
shown O -
. O +

Statistical O +
significance O +
for O +
GO O +
analysis O +
was O +
assessed O +
by O +
using O +
χ2 O +
statistics O +
with O +
Bonferroni O +
correction O +
for O +
multiple O +
hypothesis O +
testing O -
. O +

GO O +
categories O +
are O +
ordered O +
from O +
top O +
to O +
bottom O +
in O +
order O +
of O +
decreasingly O +
significant O +
bias O +
toward O +
enriched O +
genes. O -
( O -
A O -
) O +
GO O +
analysis O +
of O +
enriched O +
genes O +
in O +
hESCs. O -
( O -
B O -
) O +
GO O +
analysis O +
of O +
enriched O +
genes O +
in O +
NPs O -
. O +

To O +
summarize O -
, O +
firstly O +
immunohistochemical O +
and O +
RT O -
- O -
PCR O +
evidence O +
validated O +
that O +
the O +
cells O +
exhibited O +
expected O +
characteristics O -
; O +
secondly O -
, O +
stage O -
- O -
specific O +
marker O +
gene O +
differences O +
by O +
RT O -
- O -
PCR O +
were O +
reflected O +
accurately O +
by O +
gene O -
- O -
level O +
estimates O +
from O +
the O +
exon O +
arrays O -
; O +
thirdly O -
, O +
the O +
hESC O -
- O -
enriched O +
genes O +
were O +
coherent O +
with O +
known O +
genes O +
that O +
controlled O +
pluripotency O +
and O +
self O -
- O -
renewal O -
; O +
and O +
lastly O -
, O +
the O +
global O +
functional O +
profiles O +
exemplified O +
expected O +
biological O +
differences O +
between O +
hESC O +
and O +
NP O +
cells O -
. O +

Description O +
of O +
the O +
Regression O -
- O -
Based O +
Exon O +
Array O +
ProtocolConvinced O +
that O +
the O +
signal O +
estimates O +
from O +
the O +
exon O +
arrays O +
reflected O +
expected O +
molecular O +
and O +
biological O +
differences O +
between O +
hESCs O +
and O +
NPs O -
, O +
we O +
sought O +
to O +
identify O +
AS O +
events O -
. O +

We O +
compared O +
Cyt O -
- O -
ES O +
to O +
hCNS O -
- O -
SCns O +
to O +
illustrate O +
our O +
approach O -
. O +

First O +
we O +
normalized O +
the O +
data O +
and O +
generated O +
signal O +
estimates O +
with O +
Robust O +
Multichip O +
Analysis O +
( O -
RMA O -
) O +
and O +
estimated O +
the O +
probability O +
that O +
each O +
probeset O +
was O +
detected O +
above O +
background O +
( O -
DABG O -
) O +
using O +
publicly O +
available O +
Affymetrix O +
Power O +
Tools O +
( O -
APT O -
) O -
. O +

We O +
analyzed O +
probesets O +
that O +
( O -
i O -
) O +
comprised O +
three O +
or O +
more O +
individual O +
probes O -
; O +
( O -
ii O -
) O +
were O +
localized O +
within O +
the O +
exons O +
of O +
our O +
gene O +
models O +
with O +
evidence O +
from O +
at O +
least O +
three O +
sources O +
( O -
mRNA O -
, O +
EST O -
, O +
or O +
full O -
- O -
length O +
cDNA O -
) O -
; O +
and O +
( O -
iii O -
) O +
were O +
detected O +
above O +
background O +
in O +
at O +
least O +
one O +
of O +
the O +
cell O +
lines O -
. O +

In O +
total O -
, O +
17,430 O +
gene O +
models O +
were O +
represented O +
by O +
probesets O +
that O +
satisfied O +
these O +
criteria O -
. O +

Next O +
we O +
asked O +
whether O +
the O +
probeset O +
expression O +
within O +
each O +
gene O +
model O +
was O +
positively O +
correlated O +
for O +
any O +
two O +
cell O +
lines O -
. O +

To O +
do O +
this O +
we O +
calculated O +
the O +
Pearson O +
correlation O +
coefficient O +
between O +
the O +
vectors O +
of O +
median O +
signal O +
estimates O +
across O +
replicates O +
in O +
Cyt O -
- O -
ES O +
versus O +
hCNS O -
- O -
SCns O -
. O +

The O +
vast O +
majority O +
of O +
genes O +
( O -
> O -
80 O -
% O -
) O +
was O +
found O +
to O +
have O +
probeset O -
- O -
level O +
Pearson O +
correlation O +
coefficients O +
of O +
greater O +
than O +
0.8 O +
( O -
Figure O +
3A O -
) O -
. O +

Next O +
we O +
randomly O +
permuted O +
the O +
association O +
between O +
the O +
median O +
signal O +
estimates O +
and O +
the O +
probesets O +
for O +
each O +
gene O +
in O +
hESCs O +
( O -
or O +
hCNS O -
- O -
SCns O -
) O +
and O +
observed O +
that O +
the O +
distribution O +
of O +
Pearson O +
correlation O +
coefficients O +
for O +
the O +
permuted O +
sets O +
was O +
centered O +
at O +
zero O -
, O +
as O +
expected O +
( O -
Figure O +
3A O -
) O -
. O +

This O +
indicated O +
that O +
the O +
signal O +
estimates O +
for O +
probesets O +
between O +
hESCs O +
and O +
hCNS O -
- O -
SCns O +
were O +
highly O +
correlated O +
and O +
suggested O +
that O +
a O +
scatter O +
plot O +
of O +
probeset O +
signal O +
estimates O +
between O +
hESCs O +
and O +
hCNS O -
- O -
SCns O +
would O +
reveal O +
a O +
linear O +
relationship O +
for O +
the O +
majority O +
of O +
genes O -
. O +

We O +
hypothesized O +
that O +
a O +
linear O +
regression O +
to O +
determine O +
if O +
some O +
probesets O +
behaved O +
unexpectedly O +
in O +
one O +
cell O +
type O +
compared O +
to O +
the O +
other O +
might O +
be O +
a O +
reasonable O +
approach O +
to O +
identify O +
AS O +
exons O -
. O +

Figure O +
3Description O +
of O +
the O +
REAP O +
Algorithm O +
Comparing O +
Exon O +
Array O +
Signal O +
Estimates O +
from O +
hCNS O -
- O -
SCns O +
and O +
Cyt O -
- O -
ES O -
( O -
A O -
) O +
Histogram O +
of O +
Pearson O +
correlation O +
coefficients O +
computed O +
from O +
median O +
signal O +
estimates O +
for O +
probesets O +
between O +
Cyt O -
- O -
ES O +
versus O +
hCNS O -
- O -
SCns O +
for O +
genes O +
( O -
blue O +
bars O -
) O -
. O +

Genes O +
were O +
required O +
to O +
have O +
more O +
than O +
five O +
probesets O +
localized O +
within O +
the O +
exons O +
in O +
the O +
gene O -
. O +

Red O +
bars O +
represented O +
Pearson O +
correlation O +
coefficients O +
computed O +
from O +
exons O +
with O +
shuffled O +
signal O +
estimates. O -
( O -
B O -
) O +

Each O +
probeset O +
contained O +
probeset O -
- O -
level O +
estimates O +
from O +
three O +
replicates O +
each O -
, O +
( O -
a O -
, O +
b O -
, O +
c O -
) O +
in O +
Cyt O -
- O -
ES O +
and O +
( O -
d O -
, O +
e O -
, O +
f O -
) O +
in O +
hCNS O -
- O -
SCns O -
. O +

The O +
five O +
points O +
summarizing O +
the O +
log2 O +
probeset O -
- O -
level O +
estimates O +
are O +
indicated O +
by O +
black O +
filled O +
circles. O -
( O -
C O -
) O +

Each O +
probeset O +
was O +
summarized O +
by O +
five O +
points O -
. O +

Scatter O +
plots O +
of O +
signal O +
estimates O +
for O +
probesets O +
that O +
were O +
present O +
in O +
at O +
least O +
one O +
cell O +
type O +
( O -
Cyt O -
- O -
ES O +
or O +
hCNS O -
- O -
SCns O -
) O +
for O +
the O +
EHBP1 O +
gene O -
. O +

Probesets O +
were O +
considered O +
present O +
if O +
the O +
DABG O +
p O -
- O -
value O +
was O +
< O -
0.05 O +
for O +
all O +
three O +
replicates O +
in O +
the O +
cell O +
type O -
. O +

A O +
regression O +
line O +
derived O +
from O +
robust O +
linear O +
regression O +
with O +
MM O +
estimation O +
is O +
indicated O -
. O +

Points O +
above O +
the O +
line O +
represent O +
probesets O +
within O +
exons O +
that O +
were O +
enriched O +
in O +
Cyt O -
- O -
ES O +
and O +
points O +
below O +
represent O +
exons O +
that O +
were O +
enriched O +
in O +
hCNS O -
- O -
SCns O -
. O +

Points O +
close O +
to O +
the O +
regression O +
line O +
are O +
not O +
significantly O +
different O +
in O +
Cyt O -
- O -
ES O +
versus O +
hCNS O -
- O -
SCns O -
. O +

Boxed O +
points O +
represented O +
the O +
five O -
- O -
point O +
summary O +
of O +
a O +
probeset O +
that O +
was O +
significantly O +
enriched O +
in O +
Cyt O -
- O -
ES O +
but O +
was O +
skipped O +
in O +
hCNS O -
- O -
SCns. O -
( O -
D O -
) O +
Histogram O +
of O +
studentized O +
residuals O +
for O +
points O +
from O +
the O +
scatter O +
plot O +
in O +
( O -
C O -
) O +
in O +
EHBP1. O -
( O -
E O -
) O +
The O +
histogram O +
of O +
studentized O +
residuals O +
for O +
all O +
points O +
for O +
all O +
analyzed O +
probesets O +
( O -
100 O +
bins O -
) O -
. O -
( O -
F O -
) O +

The O +
scatter O +
plot O +
of O +
studentized O +
residuals O +
generated O +
from O +
comparing O +
Cyt O -
- O -
ES O +
versus O +
hCNS O -
- O -
SCns O +
and O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
ES O +
of O +
5,000 O +
randomly O +
chosen O +
probesets O -
. O +

Here O -
, O +
a O +
possible O +
representation O +
of O +
the O +
data O +
was O +
explored O -
. O +

If O +
we O +
had O +
N O +
replicates O +
in O +
one O +
condition O +
and O +
M O +
replicates O +
in O +
the O +
other O -
, O +
we O +
could O +
consider O +
N*M O +
points O +
if O +
we O +
analyzed O +
every O +
possible O +
pairing O -
. O +

For O +
instance O -
, O +
three O +
replicate O +
signal O +
estimates O +
for O +
every O +
probeset O +
per O +
cell O +
line O -
, O +
such O +
as O +
signal O +
estimates O +
a O -
, O +
b O -
, O +
and O +
c O +
in O +
hESCs O +
and O +
d O -
, O +
e O -
, O +
and O +
f O +
in O +
hCNS O -
- O -
SCns O -
, O +
would O +
translate O +
to O +
pairing O +
every O +
signal O +
( O -
d O -
, O -
a O -
) O -
, O +
( O -
d O -
, O -
b O -
) O -
, O +
( O -
d O -
, O -
c O -
) O +
… O +
( O -
f O -
, O -
a O -
) O -
, O +
( O -
f O -
, O -
b O -
) O -
, O +
( O -
f O -
, O -
c O -
) O +
for O +
linear O +
regression O +
( O -
Figure O +
3B O -
) O -
. O +

Instead O -
, O +
pairing O +
the O +
signal O +
estimates O +
of O +
all O +
replicates O +
in O +
one O +
condition O +
to O +
the O +
median O +
of O +
the O +
other O +
would O +
only O +
require O +
N O +
+ O +
M O +
− O +
1 O +
points O +
and O +
would O +
capture O +
the O +
variation O +
of O +
the O +
signal O +
estimates O +
of O +
each O +
probeset O -
. O +

For O +
example O -
, O +
we O +
considered O +
( O -
d O -
, O -
b O -
) O -
, O +
( O -
e O -
, O -
a O -
) O -
, O +
( O -
e O -
, O -
b O -
) O -
, O +
( O -
e O -
, O -
c O -
) O -
, O +
and O +
( O -
f O -
, O -
b O -
) O +
points O +
where O +
b O +
and O +
d O +
were O +
the O +
median O +
intensities O +
for O +
the O +
replicates O +
in O +
Cyt O -
- O -
ES O +
and O +
hCNS O -
- O -
SCns O -
, O +
respectively O +
( O -
Figure O +
3B O -
) O -
. O +

A O +
scatter O +
plot O +
of O +
all O +
probesets O +
of O +
the O +
EHBP1 O +
( O -
EH O +
domain O +
binding O +
protein O -
, O +
RefSeq O +
identifier O +
NM_015252 O -
) O +
is O +
shown O +
in O +
Figure O +
3C O +
in O +
the O +
format O +
described O -
. O +

Each O +
probeset O +
was O +
represented O +
by O +
5 O +
points O +
of O +
log O -
- O -
transformed O +
( O -
base O +
2 O -
) O +
values O -
; O +
and O +
each O +
point O +
on O +
the O +
scatter O +
plot O +
reflected O +
the O +
extent O +
of O +
inclusion O +
of O +
an O +
exon O +
in O +
hESCs O +
and O +
in O +
hCNS O -
- O -
SCns O +
( O -
Figure O +
3C O -
) O -
.A O +
classical O +
linear O +
regression O +
model O +
could O +
be O +
proposed O +
to O +
fit O +
the O +
response O +
variable O +
yij O -
, O +
the O +
log2 O +
expression O +
of O +
probeset O +
i O +
in O +
cell O -
- O -
type O +
j O +
( O -
for O +
example O -
, O +
j O +
is O +
Cyt O -
- O -
ESC O -
) O +
to O +
explanatory O +
variables O +
xik O -
, O +
and O +
the O +
log2 O +
expression O +
of O +
probeset O +
i O +
in O +
cell O +
type O +
k O +
( O -
for O +
example O -
, O +
k O +
is O +
hCNS O -
- O -
SCns O -
) O -
. O +

However O -
, O +
classical O +
linear O +
regression O +
by O +
least O -
- O -
squares O +
estimation O +
is O +
biased O +
because O +
the O +
least O +
squares O +
predictions O +
are O +
strongly O +
influenced O +
by O +
the O +
outliers O -
, O +
leading O +
to O +
completely O +
incorrect O +
regression O +
line O +
estimates O -
, O +
masking O +
of O +
the O +
outliers O -
, O +
and O +
incorrect O +
predictions O +
of O +
outliers O -
. O +

Therefore O -
, O +
we O +
applied O +
M O -
- O -
estimation O +
robust O +
regression O +
to O +
estimate O +
the O +
line O -
, O +
which O +
is O +
less O +
sensitive O +
to O +
outliers O -
. O +

Fitting O +
was O +
performed O +
using O +
an O +
iterated O -
, O +
re O -
- O -
weighted O +
least O +
squares O +
analysis O -
. O +

Our O +
assumption O +
was O +
that O +
most O +
of O +
the O +
points O +
were O +
" O -
correct O -
, O -
" O +
i.e. O -
, O +
that O +
most O +
of O +
the O +
exons O +
were O +
constitutively O +
spliced O -
. O +

Thus O -
, O +
robust O +
regression O +
would O +
find O +
the O +
line O +
that O +
was O +
least O +
dependent O +
on O +
outliers O -
, O +
which O +
would O +
be O +
potential O +
AS O +
exons O -
. O +

This O +
assumption O +
was O +
substantiated O +
by O +
our O +
observation O +
that O -
, O +
using O +
publicly O +
available O +
ESTs O +
and O +
mRNAs O -
, O +
a O +
minority O +
of O +
human B-Species +
exons O +
( O -
7 O -
% O -
) O +
have O +
evidence O +
for O +
exon O -
- O -
skipping O -
, O +
the O +
most O +
common O +
form O +
of O +
AS O -
. O +

Using O +
robust O +
regression O -
, O +
the O +
regression O +
line O +
for O +
Cyt O -
- O -
ESC O +
versus O +
hCNS O -
- O -
SCns O +
in O +
the O +
EHBP1 O +
gene O +
is O +
illustrated O +
in O +
Figure O +
3C O -
. O +

The O +
boxed O +
points O +
belonged O +
to O +
a O +
probeset O +
that O +
was O +
enriched O +
in O +
hESCs O +
but O +
depleted O +
in O +
hCNS O -
- O -
SCns O -
, O +
which O +
was O +
suspected O +
to O +
be O +
due O +
to O +
AS O -
. O +

The O +
difference O +
between O +
the O +
actual O +
and O +
regression O -
- O -
based O +
predicted O +
value O -
, O +
normalized O +
by O +
the O +
estimate O +
of O +
its O +
standard O +
deviation O -
, O +
is O +
called O +
the O +
studentized O +
residuals O -
. O +

Studentized O +
residuals O +
were O +
computed O +
for O +
all O +
probeset O +
pairs O +
in O +
EHBP1 O -
, O +
and O +
the O +
histogram O +
depicting O +
their O +
distribution O +
is O +
illustrated O +
in O +
Figure O +
3D O -
. O +

As O +
expected O -
, O +
the O +
mean O +
of O +
the O +
distribution O +
was O +
close O +
to O +
zero O -
, O +
and O +
the O +
distribution O +
was O +
approximated O +
by O +
a O +
t O -
- O -
distribution O +
with O +
n O -
- O -
p-1 O +
degrees O +
of O +
freedom O -
, O +
where O +
n O +
was O +
the O +
number O +
of O +
points O +
on O +
the O +
scatter O +
plot O -
, O +
and O +
the O +
number O +
of O +
parameters O +
p O +
was O +
2 O -
. O +

The O +
boxed O +
points O +
had O +
studentized O +
residuals O +
of O +
1.829 O -
, O +
3.104 O -
, O +
2.634 O -
, O +
3.012 O -
, O +
and O +
2.125 O +
with O +
p O -
- O -
values O +
of O +
0.034 O -
, O +
0.00119 O -
, O +
0.00477 O -
, O +
0.00158 O -
, O +
and O +
0.01780 O -
, O +
respectively O -
, O +
computed O +
based O +
on O +
the O +
t O -
- O -
distribution O +
( O -
Figure O +
3C O -
) O -
. O +

At O +
a O +
stringent O +
p O -
- O -
value O +
cutoff O +
of O +
0.01 O -
, O +
four O +
of O +
the O +
five O +
studentized O +
residuals O +
were O +
designated O +
as O +
significant O +
" O -
outliers O -
, O -
" O +
indicating O +
that O +
the O +
probeset O +
was O +
" O -
unusual O -
. O -
" O +
RT O -
- O -
PCR O +
confirmed O +
that O +
the O +
exon O -
, O +
represented O +
by O +
the O +
probeset O -
, O +
was O +
indeed O +
differentially O +
included O +
in O +
hESCs O +
and O +
skipped O +
in O +
hCNS O -
- O -
SCns O +
( O -
Figure O +
7B O -
) O -
. O +

Applying O +
this O +
approach O +
to O +
all O +
gene O +
models O +
revealed O +
that O -
, O +
as O +
expected O -
, O +
the O +
majority O +
of O +
studentized O +
residuals O +
are O +
centered O +
at O +
zero O +
( O -
Figure O +
3E O -
) O -
. O +

Thus O +
far O +
in O +
the O +
example O -
, O +
our O +
analysis O +
was O +
based O +
on O +
regression O +
of O +
hESCs O +
( O -
y O -
- O -
axis O -
) O +
versus O +
hCNS O -
- O -
SCns O +
( O -
x O -
- O -
axis O -
) O +
( O -
Figure O +
3B–3D O -
) O -
. O +

However O -
, O +
robust O +
regression O +
as O +
described O +
was O +
not O +
symmetrical O -
, O +
i.e. O -
, O +
parameter O +
estimation O +
of O +
y O +
as O +
a O +
function O +
of O +
x O +
was O +
not O +
the O +
same O +
as O +
that O +
of O +
x O +
as O +
a O +
function O +
of O +
y. O +
The O +
negative O +
slope O +
revealed O +
that O +
probesets O +
enriched O +
in O +
hESCs O +
versus O +
hCNS O -
- O -
SCns O +
( O -
positive O +
valued O -
) O -
, O +
were O +
expectedly O +
depleted O +
when O +
hCNS O -
- O -
SCns O +
was O +
compared O +
to O +
hESCs O +
( O -
negative O +
valued O -
; O +
Figure O +
3F O -
) O -
. O +

As O +
our O +
method O +
for O +
predicting O +
candidate O +
alternative O +
exons O +
was O +
based O +
on O +
identification O +
of O +
outliers O +
using O +
robust O +
regression O -
, O +
we O +
named O +
the O +
method O +
REAP O -
. O +

Identification O +
and O +
Removal O +
of O +
False O +
PositivesIn O +
the O +
process O +
of O +
experimentally O +
validating O +
our O +
predictions O -
, O +
we O +
encountered O +
three O +
main O +
sources O +
of O +
false O +
positives O +
( O -
FP O -
) O +
from O +
robust O +
regression O -
. O +

First O -
, O +
we O +
identified O +
genes O +
with O +
probeset O +
signal O +
estimates O +
that O +
were O +
poorly O +
correlated O +
and O +
were O +
not O +
amenable O +
to O +
our O +
method O -
. O +

As O +
an O +
example O -
, O +
the O +
median O +
probeset O +
signal O +
estimates O +
in O +
hESCs O +
and O +
hCNS O -
- O -
SCns O +
of O +
the O +
FIP1L1 O +
gene O +
( O -
gene O +
identifiers O +
BC011543 O -
, O +
AL136910 O -
) O +
had O +
a O +
Pearson O +
correlation O +
coefficient O +
of O +
0.38 O -
, O +
and O +
the O +
distribution O +
of O +
points O +
was O +
not O +
amenable O +
to O +
robust O +
regression O +
( O -
Figure O +
4A O -
) O -
. O +

To O +
avoid O +
inappropriate O +
application O +
of O +
REAP O +
and O +
generating O +
false O +
predictions O -
, O +
we O +
empirically O +
determined O +
that O +
a O +
gene O +
had O +
to O +
have O +
a O +
Pearson O +
correlation O +
coefficient O +
cutoff O +
of O +
0.6 O +
before O +
being O +
amenable O +
to O +
REAP O +
analysis O -
. O +

Next O -
, O +
we O +
managed O +
two O +
additional O +
sources O +
of O +
FPs O -
, O +
namely O +
" O -
high O -
- O -
leverage O -
" O +
and O +
" O -
high O -
- O -
influence O -
" O +
points O -
, O +
which O +
we O +
were O +
able O +
to O +
identify O +
by O +
computing O +
the O +
following O +
metrics O -
. O +

For O +
every O +
point O -
, O +
we O +
computed O +
( O -
i O -
) O +
the O +
studentized O +
residual O +
( O -
as O +
described O +
above O -
) O -
, O +
( O -
ii O -
) O +
the O +
influence O -
, O +
and O +
( O -
iii O -
) O +
the O +
leverage O +
( O -
see O +
Materials O +
and O +
Methods O +
for O +
more O +
details O -
) O -
. O +

Leverage O +
assessed O +
how O +
far O +
away O +
a O +
value O +
of O +
the O +
independent O +
variable O +
was O +
from O +
the O +
mean O +
value O -
; O +
the O +
farther O +
away O +
the O +
observation O +
the O +
more O +
leverage O +
it O +
had O -
. O +

The O +
influence O +
of O +
a O +
point O +
was O +
related O +
to O +
its O +
covariance O +
ratio O -
: O +
a O +
covariance O +
ratio O +
larger O +
( O -
or O +
smaller O -
) O +
than O +
1 O +
implied O +
that O +
the O +
point O +
was O +
closer O +
( O -
or O +
farther O -
) O +
than O +
was O +
typical O +
to O +
the O +
regression O +
line O -
, O +
so O +
removing O +
it O +
would O +
hurt O +
( O -
or O +
help O -
) O +
the O +
accuracy O +
of O +
the O +
line O +
and O +
would O +
increase O +
( O -
or O +
decrease O -
) O +
the O +
error O +
term O +
variance O -
. O +

Influence O +
was O +
computed O +
as O +
the O +
absolute O +
difference O +
between O +
the O +
covariance O +
ratio O +
and O +
unity O -
. O +

To O +
illustrate O +
further O -
, O +
a O +
point O +
was O +
classified O +
as O +
an O +
" O -
outlier O -
" O +
if O +
it O +
had O +
a O +
large O +
studentized O +
residual O +
( O -
p O +
< O +
0.01 O -
) O +
and O +
low O +
leverage O +
( O -
boxed O +
point O +
" O -
a O -
" O -
) O -
; O +
as O +
a O +
" O -
high O -
- O -
leverage O -
" O +
point O +
if O +
it O +
had O +
a O +
low O +
studentized O +
residual O +
and O +
high O +
leverage O +
( O -
boxed O +
point O +
" O -
b O -
" O -
) O -
; O +
and O +
as O +
a O +
" O -
high O -
- O -
influence O -
" O +
point O +
if O +
it O +
had O +
a O +
high O +
studentized O +
residual O -
, O +
high O +
leverage O -
, O +
and O +
high O +
influence O +
( O -
boxed O +
point O +
" O -
c O -
" O -
; O +
Figure O +
4B O -
) O -
. O +

Points O +
that O +
resembled O +
boxed O +
point O +
" O -
a O -
" O +
were O +
designated O +
as O +
potential O +
AS O +
events O -
. O +

For O +
example O -
, O +
four O +
of O +
the O +
five O +
boxed O +
points O +
in O +
Figure O +
3C O +
were O +
" O -
outliers O -
, O -
" O +
and O +
RT O -
- O -
PCR O +
validation O +
indicated O +
that O +
the O +
exon O +
represented O +
by O +
the O +
probeset O +
was O +
indeed O +
skipped O +
in O +
hCNS O -
- O -
SCns O +
( O -
EHBP1 O -
, O +
Figure O +
7B O -
) O -
. O +

Points O +
that O +
were O +
" O -
high O -
- O -
leverage O -
, O -
" O +
such O +
as O +
the O +
five O +
points O +
in O +
the O +
CLCN2 O +
gene O -
, O +
were O +
experimentally O +
verified O +
to O +
be O +
a O +
FP O +
( O -
Figure O +
4C O -
; O +
unpublished O +
data O -
) O -
. O +

Points O +
that O +
were O +
" O -
high O -
- O -
influence O -
, O -
" O +
such O +
as O +
the O +
four O +
of O +
five O +
boxed O +
points O +
in O +
the O +
ABCA3 O +
gene O +
were O +
also O +
experimentally O +
verified O +
to O +
be O +
a O +
FP O +
( O -
Figure O +
4D O -
; O +
unpublished O +
data O -
) O -
. O +

In O +
conclusion O -
, O +
in O +
order O +
to O +
reduce O +
the O +
FP O +
rate O -
, O +
all O +
points O +
were O +
evaluated O +
according O +
to O +
the O +
metrics O +
described O -
, O +
and O +
points O +
that O +
were O +
significant O +
" O -
outliers O -
" O +
were O +
considered O +
putative O +
AS O +
events O -
. O +

Figure O +
4Sources O +
of O +
False O +
Positives O -
( O -
A O -
) O +
Scatter O +
plot O +
of O +
points O +
for O +
the O +
FIP1L1 O +
gene O +
and O +
the O +
line O +
representing O +
the O +
robust O +
regression O +
estimate. O -
( O -
B O -
) O +

Boxed O +
point O +
" O -
a O -
" O +
represents O +
a O +
significant O +
" O -
outlier O -
" O +
( O -
with O +
a O +
significantly O +
different O +
studentized O +
residual O +
and O +
low O +
leverage O -
) O -
. O +

Boxed O +
point O +
" O -
b O -
" O +
represents O +
a O +
" O -
high O +
leverage O -
" O +
point O +
( O -
low O +
studentized O +
residual O +
and O +
a O +
high O +
leverage O -
) O -
. O +

Boxed O +
point O +
" O -
c O -
" O +
represents O +
a O +
" O -
high O +
influence O -
" O +
point O +
( O -
high O +
studentized O +
residual O -
, O +
high O +
leverage O -
, O +
and O +
high O +
influence O -
) O -
. O -
( O -
C O -
) O +
Scatter O +
plot O +
of O +
points O +
for O +
the O +
CLCN2 O +
gene O -
. O +

Boxed O +
points O +
represent O +
" O -
high O +
leverage O -
" O +
points. O -
( O -
D O -
) O +
Scatter O +
plot O +
of O +
points O +
for O +
the O +
ABCA3 O +
gene O -
. O +

Boxed O +
points O +
represent O +
" O -
high O +
influence O -
" O +
points O -
. O +

Global O +
Identification O +
and O +
Characterization O +
of O +
REAP O -
[ O -
+ O -
] O +
ExonsREAP O +
was O +
applied O +
to O +
identify O +
AS O +
events O +
in O +
NPs O +
compared O +
to O +
hESCs O -
: O +
Cyt O -
- O -
NP O +
versus O +
Cyt O -
- O -
ES O -
; O +
HUES6-NP O +
versus O +
HUES6-ES O -
; O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
ES O -
, O +
and O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O -
. O +

After O +
removing O +
potential O +
FPs O -
, O +
11,348 O +
genes O +
containing O +
158,657 O +
probesets O +
were O +
scored O +
by O +
REAP.As O +
described O +
above O -
, O +
for O +
each O +
pair O +
of O +
cell O +
lines O +
compared O -
, O +
each O +
probset O +
was O +
represented O +
by O +
five O +
points O -
, O +
where O +
each O +
point O +
was O +
defined O +
a O +
significant O +
outlier O +
if O +
it O +
had O +
a O +
high O +
residual O +
( O -
p O +
< O +
0.01 O -
) O -
, O +
low O +
influence O -
, O +
and O +
high O +
leverage O -
. O +

Points O +
per O +
probeset O +
should O +
be O +
correlated O -
; O +
in O +
other O +
words O -
, O +
if O +
one O +
point O +
was O +
a O +
significant O +
outlier O -
, O +
the O +
other O +
points O +
were O +
expected O +
to O +
be O +
outliers O +
as O +
well O -
. O +

To O +
ensure O +
that O +
this O +
was O +
the O +
case O -
, O +
we O +
counted O +
the O +
number O +
of O +
probesets O +
with O +
N O +
significant O +
outliers O -
, O +
where O +
N O +
was O +
varied O +
from O +
0 O +
to O +
5 O -
. O +

Next O -
, O +
the O +
identity O +
of O +
the O +
probesets O +
and O +
points O +
derived O +
from O +
them O +
were O +
exchanged O +
with O +
other O +
probesets O -
, O +
keeping O +
constant O +
the O +
total O +
number O +
of O +
points O +
that O +
were O +
considered O +
significant O +
outliers O -
. O +

At O +
N O +
= O +
0 O -
, O +
we O +
observed O +
approximately O +
equal O +
numbers O +
of O +
probesets O +
in O +
the O +
actual O +
versus O +
shuffled O +
controls O -
. O +

In O +
contrast O -
, O +
we O +
observed O +
that O +
there O +
were O +
1.5 O +
times O +
more O +
probesets O +
with O +
N O +
= O +
2 O +
significant O +
outliers O +
relative O +
to O +
shuffled O +
controls O -
; O +
12–31 O +
times O +
more O +
probesets O +
with O +
N O +
= O +
3 O -
; O +
and O +
17–612 O +
times O +
more O +
probesets O +
that O +
had O +
N O +
= O +
4 O +
significant O +
outliers O +
( O -
Figure O +
5A O -
; O +
see O +
Table O +
S1 O -
) O -
. O +

For O +
example O -
, O +
in O +
hCNS O -
- O -
SCns O +
compared O +
to O +
Cyt O -
- O -
ES O -
, O +
approximately O +
0.39 O -
% O +
( O -
490 O +
of O +
124,604 O -
) O +
of O +
probesets O +
had O +
three O +
significant O +
outliers O +
and O +
0.25 O -
% O +
( O -
308 O +
probesets O -
) O +
had O +
four O +
significant O +
outliers O -
, O +
relative O +
to O +
0.02 O -
% O +
and O +
0 O -
% O +
of O +
shuffled O +
controls O -
, O +
respectively O -
. O +

Figure O +
5Correlation O +
between O +
" O -
Outliers" O -
( O -
A O -
) O +
The O +
number O +
of O +
probesets O +
with O +
N O +
significant O +
" O -
outliers O -
" O +
was O +
determined O +
for O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
ES O -
, O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O -
, O +
Cyt O -
- O -
NPs O +
versus O +
Cyt O -
- O -
ES O -
, O +
and O +
HUES6-NPs O +
versus O +
HUES6-ES O +
( O -
N O +
= O +
0 O -
, O +
1 O -
, O +
2 O -
, O +
3 O -
, O +
4 O -
, O +
5 O -
) O -
. O +

For O +
comparison O -
, O +
points O +
to O +
probeset O +
relationships O +
were O +
randomly O +
permuted O -
, O +
retaining O +
the O +
same O +
number O +
of O +
" O -
outliers O -
. O -
" O +

Vertical O +
bars O +
represent O +
the O +
ratio O +
between O +
the O +
number O +
of O +
actual O +
points O +
and O +
the O +
randomly O +
permutated O +
sets. O -
( O -
B O -
) O +
Similar O +
to O +
( O -
A O -
) O -
, O +
except O +
points O +
were O +
counted O +
as O +
" O -
outliers O -
" O +
only O +
if O +
they O +
were O +
" O -
outliers O -
" O +
in O +
both O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
ES O +
and O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O +
( O -
combined O +
hCNS O -
- O -
SCns O +
versus O +
hESC O -
; O +
blue O +
bars O -
) O -
; O +
in O +
both O +
HUES6-NP O +
versus O +
HUES6-ES O +
and O +
Cyt O -
- O -
NP O +
versus O +
Cyt O -
- O -
ES O +
( O -
combined O +
derived O +
NP O +
versus O +
hESC O -
; O +
red O +
bars O -
) O -
; O +
and O +
in O +
all O +
four O +
comparisons O +
( O -
combined O +
NP O +
versus O +
hESC O -
; O +
yellow O +
bar O -
) O -
.Next O +
we O +
asked O +
whether O +
the O +
overlap O +
between O +
related O +
comparisons O +
was O +
higher O +
than O +
expected O -
. O +

Comparing O +
the O +
significant O +
probesets O +
between O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
ES O +
and O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O +
revealed O +
672 O +
significant O +
probesets O +
( O -
N O +
≥ O +
2 O -
) O -
, O +
whereas O +
if O +
we O +
shuffled O +
the O +
associations O +
between O +
probeset O +
identity O +
and O +
significant O +
outliers O -
, O +
only O +
four O +
significant O +
probesets O +
( O -
N O +
≥ O +
2 O -
) O +
were O +
identified O -
— O -
a O +
168-fold O +
enrichment O +
( O -
Figure O +
5B O -
, O +
Table O +
S1 O -
) O -
. O +

A O +
total O +
of O +
236 O +
significant O +
probesets O +
overlapped O +
when O +
we O +
compared O +
the O +
derived O +
NPs O +
to O +
hESCs O +
( O -
Cyt O -
- O -
NP O +
versus O +
Cyt O -
- O -
ES O +
and O +
HUES6-NP O +
versus O +
HUES6-ES O -
) O -
, O +
relative O +
to O +
seven O +
significant O +
probesets O +
( O -
34-fold O +
enrichment O -
) O -
.At O +
a O +
cutoff O +
of O +
two O +
significant O +
outliers O -
, O +
1,737 O +
probesets O +
contained O +
in O +
internal O +
exons O +
were O +
defined O +
as O +
positive O +
REAP O +
predictions O +
( O -
hereafter O +
called O +
REAP O -
[ O -
+ O -
] O -
) O +
exons O -
— O -
candidate O +
AS O +
events O +
that O +
distinguished O +
NP O +
from O +
hESC O -
. O +

Surprisingly O -
, O +
we O +
observed O +
that O +
the O +
majority O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O +
were O +
specific O +
to O +
the O +
pair O +
of O +
hESC O +
and O +
NP O +
that O +
was O +
compared O -
, O +
likely O +
reflecting O +
differences O +
in O +
genetic O +
origins O +
and/or O +
culturing O +
and O +
differentiation O +
conditions O +
of O +
the O +
cell O +
lines O -
: O +
614 O +
REAP O -
[ O -
+ O -
] O +
events O +
were O +
unique O +
to O +
hCNS O -
- O -
SCns O +
versus O +
HUE6-ES O -
; O +
220 O +
were O +
unique O +
to O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
ES O -
; O +
439 O +
were O +
unique O +
to O +
HUES6-NP O +
versus O +
HUES6-ES O -
; O +
and O +
250 O +
were O +
unique O +
to O +
Cyt O -
- O -
NP O +
versus O +
Cyt O -
- O -
ES O -
. O +

The O +
shared O +
events O +
between O +
pairs O +
of O +
comparisons O +
made O +
up O +
a O +
minority O +
of O +
the O +
total O +
number O +
identified O -
: O +
102 O +
REAP O -
[ O -
+ O -
] O +
events O +
were O +
found O +
to O +
be O +
in O +
common O +
between O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
ES O +
and O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O -
; O +
48 O +
between O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O +
and O +
HUES6-NP O +
versus O +
HUES6-ES O -
; O +
and O +
only O +
17 O +
between O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
ES O +
and O +
Cyt O -
- O -
NP O +
versus O +
Cyt O -
- O -
ES O +
( O -
Table O +
S2 O -
) O -
. O +

Comparison O +
of O +
REAP O +
to O +
EST O -
- O -
Based O +
Method O +
and O +
ACEScanTraditionally O -
, O +
AS O +
exons O +
were O +
discovered O +
by O +
using O +
EST O +
alignments O +
to O +
genomic O +
loci O -
, O +
and O +
also O +
more O +
recently O +
by O +
computational O +
algorithms O +
that O +
used O +
sequence O +
information O +
extracted O +
from O +
multiple O +
genomes O -
. O +

Here O -
, O +
we O +
compared O +
REAP O +
predictions O +
to O +
both O +
approaches O -
. O +

In O +
the O +
first O +
comparison O -
, O +
publicly O +
available O +
ESTs O +
and O +
mRNA O +
transcripts O +
were O +
aligned O +
to O +
the O +
human B-Species +
genome O +
sequence O -
. O +

13,934 O +
exons O +
with O +
evidence O +
for O +
exon O -
- O -
skipping O +
and/or O +
inclusion O +
( O -
EST O -
- O -
SE O +
for O +
EST O -
- O -
verified O +
skipped O +
exons O -
) O +
were O +
generated O -
, O +
comprising O +
∼7 O -
% O +
of O +
all O +
internal O +
exons O -
. O +

First O +
we O +
analyzed O +
Cyt O -
- O -
ES O +
versus O +
hCNS O -
- O -
SCns O -
. O +

If O +
we O +
required O +
that O +
none O +
of O +
the O +
points O +
per O +
probeset O +
( O -
exon O -
) O +
was O +
significant O -
, O +
6 O -
% O +
( O -
4,402 O +
of O +
71,731 O -
) O +
of O +
exons O +
( O -
after O +
probeset O +
mapping O -
) O +
had O +
evidence O +
for O +
EST O -
- O -
SE O +
( O -
Figure O +
6A O -
) O -
. O +

Shuffling O +
the O +
mapping O +
between O +
these O +
probesets O +
and O +
exons O +
resulted O +
in O +
8 O -
% O +
( O -
5,777 O +
of O +
71,731 O -
) O +
of O +
exons O +
with O +
evidence O +
for O +
EST O -
- O -
SE O +
( O -
Figure O +
6A O -
) O -
. O +

These O +
percentages O +
were O +
not O +
significantly O +
different O +
from O +
the O +
7 O -
% O +
of O +
exons O +
with O +
EST O +
evidence O +
for O +
AS O +
observed O +
from O +
using O +
all O +
exons O -
. O +

By O +
raising O +
the O +
requirement O +
that O +
probesets O +
had O +
to O +
contain O +
at O +
least O +
one O +
significant O +
point O +
to O +
five O +
significant O +
points O -
, O +
the O +
percentage O +
of O +
EST O -
- O -
SE O +
increased O +
dramatically O +
from O +
11 O -
% O +
( O -
531 O +
of O +
4,898 O +
exons O -
) O +
to O +
26 O -
% O +
( O -
33 O +
of O +
126 O -
) O -
. O +

In O +
comparison O -
, O +
the O +
shuffled O +
probesets O +
at O +
the O +
same O +
requirements O +
remained O +
at O +
∼8 O -
% O -
, O +
rising O +
slightly O +
to O +
11 O -
% O +
at O +
five O +
points O -
, O +
due O +
to O +
small O +
sample O +
sizes O -
. O +

Similar O +
trends O +
were O +
observed O +
with O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O +
and O +
the O +
derived O +
NPs O +
versus O +
hESCs O +
( O -
Figure O +
6A O -
) O -
. O +

Therefore O -
, O +
we O +
concluded O +
that O +
REAP O -
[ O -
+ O -
] O +
exons O +
were O +
enriched O +
for O +
AS O +
events O +
independently O +
identified O +
by O +
a O +
transcript O -
- O -
based O +
approach O -
. O +

Figure O +
6Comparison O +
of O +
REAP O +
Predictions O +
for O +
hCNS O -
- O -
SCns O +
versus O +
Cyt O -
- O -
hES O -
, O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O -
, O +
Cyt O -
- O -
NP O +
versus O +
Cyt O -
- O -
ES O -
, O +
and O +
HUES6-NPs O +
versus O +
HUES6-ES O +
with O +
Alternative O +
Exons O +
Identified O +
by O +
an O +
EST O -
- O -
Based O +
Method O +
and O +
ACEScan O -
( O -
A O -
) O +
Black O -
- O -
filled O +
squares O +
represented O +
the O +
fraction O +
of O +
exons O +
containing O +
probesets O +
with O +
N O +
significant O +
points O +
that O +
had O +
EST O +
evidence O +
for O +
exon O +
inclusion O +
or O +
exclusion O +
( O -
N O +
= O +
0 O -
, O +
1 O -
, O +
2 O -
, O +
3 O -
, O +
4 O +
and O +
5 O -
) O -
. O +

White O -
- O -
filled O +
triangles O +
represented O +
similarly O +
computed O +
fractions O +
with O +
permuted O +
probeset O +
to O +
exon O +
mappings. O -
( O -
B O -
) O +
Black O -
- O -
filled O +
squares O +
represented O +
the O +
fraction O +
of O +
exons O +
containing O +
probesets O +
with O +
N O +
significant O +
points O +
that O +
had O +
ACEScan O +
positive O +
scores O -
, O +
indicative O +
of O +
evolutionarily O +
conserved O +
alternative O +
exons O -
. O +

White O -
- O -
filled O +
triangles O +
represented O +
similarly O +
computed O +
fractions O +
with O +
permuted O +
probeset O +
to O +
exon O +
mappings O -
. O +

Next O -
, O +
we O +
compared O +
REAP O +
predictions O +
to O +
a O +
computational O +
approach O +
of O +
identifying O +
exons O +
with O +
AS O +
conserved O +
in O +
human B-Species +
and O +
mouse B-Species -
, O +
ACEScan O +
[ O -
55 O -
] O -
. O +

ACEScan O +
receives O +
as O +
input O +
orthologous O +
human B-Species -
– O -
mouse B-Species +
exon O +
pairs O +
and O +
flanking O +
intronic O +
regions O +
and O +
computes O +
sequence O +
features O +
and O +
integrates O +
the O +
features O +
into O +
a O +
machine O -
- O -
learning O +
algorithm O +
to O +
assign O +
a O +
real O -
- O -
valued O +
score O +
to O +
the O +
exon O -
. O +

A O +
positive O +
score O +
indicated O +
a O +
higher O +
likelihood O +
of O +
being O +
AS O +
in O +
both O +
human B-Species +
and O +
mouse B-Species -
. O +

ACEScan O +
was O +
updated O +
in O +
the O +
following O +
ways O -
. O +

Firstly O -
, O +
instead O +
of O +
relying O +
on O +
orthology O +
information O +
by O +
Ensembl O -
, O +
and O +
then O +
aligning O +
flanking O +
introns O +
in O +
" O -
orthologous O -
" O +
exons O -
, O +
conserved O +
exonic O +
and O +
intronic O +
regions O +
in O +
human B-Species +
and O +
mouse B-Species +
from O +
genome O -
- O -
wide O +
multiple O +
alignments O +
were O +
extracted O -
. O +

Secondly O -
, O +
whereas O +
in O +
our O +
previous O +
analysis O +
exons O +
from O +
the O +
longest O +
transcript O +
in O +
Ensembl O +
were O +
utilized O -
, O +
now O +
we O +
collapsed O +
all O +
the O +
transcripts O +
available O +
at O +
the O +
UCSC O +
genome O +
browser O +
and O +
analyzed O +
all O +
exons O +
in O +
the O +
entire O +
gene O +
loci O -
. O +

ACEScan O +
was O +
utilized O +
to O +
assign O +
ACEScan O +
scores O +
to O +
all O +
∼162,000 O +
internal O +
exons O +
in O +
our O +
genes O -
. O +

Exons O +
annotated O +
as O +
first O +
or O +
last O +
exons O +
in O +
Refseq O +
mRNAs O +
were O +
excluded O +
from O +
our O +
analysis O -
, O +
resulting O +
in O +
4,487 O +
positive O -
- O -
scoring O +
exons O -
, O +
2-fold O +
more O +
exons O +
than O +
originally O +
published O -
. O +

Here O +
we O +
repeated O +
our O +
analysis O +
with O +
exons O +
with O +
positive O +
ACEScan O +
scores O +
( O -
ACE O -
[ O -
+ O -
] O -
) O +
instead O +
of O +
EST O -
- O -
SEs O -
. O +

If O +
we O +
required O +
that O +
none O +
of O +
the O +
points O +
per O +
probeset O +
( O -
exon O -
) O +
was O +
significant O -
, O +
2 O -
% O +
( O -
1,645 O +
of O +
71,731 O -
) O +
of O +
exons O +
( O -
after O +
probeset O +
mapping O -
) O +
were O +
ACE O -
[ O -
+ O -
] O +
( O -
Figure O +
6B O -
) O -
. O +

Shuffling O +
the O +
mapping O +
between O +
these O +
probesets O +
and O +
exons O +
resulted O +
in O +
3 O -
% O +
( O -
2,044 O +
of O +
71,731 O -
) O +
of O +
exons O +
being O +
ACE O -
[ O -
+ O -
] O +
( O -
Figure O +
6B O -
) O -
. O +

These O +
percentages O +
were O +
not O +
significantly O +
different O +
from O +
the O +
2.7 O -
% O +
observed O +
from O +
all O +
exons O +
( O -
4,487 O +
of O +
the O +
162,000 O +
exons O +
that O +
were O +
scored O +
by O +
ACEScan O -
) O -
. O +

By O +
raising O +
the O +
requirement O +
that O +
probesets O +
had O +
to O +
contain O +
five O +
significant O +
points O -
, O +
the O +
percentage O +
of O +
ACE O -
[ O -
+ O -
] O +
exons O +
increased O +
from O +
4 O -
% O +
to O +
11 O -
% O -
. O +

However O -
, O +
the O +
sample O +
sizes O +
were O +
small O -
. O +

In O +
comparison O -
, O +
the O +
shuffled O +
probesets O +
at O +
the O +
same O +
requirements O +
remained O +
at O +
∼4 O -
% O -
. O +

Similar O +
overall O +
trends O +
were O +
observed O +
with O +
hCNS O -
- O -
SCns O +
versus O +
HUES6-ES O +
and O +
the O +
derived O +
NPs O +
versus O +
hESCs O +
( O -
Figure O +
6B O -
) O -
. O +

In O +
total O -
, O +
7.5 O -
% O +
( O -
131 O +
of O +
1,737 O -
) O +
of O +
REAP O +
[ O -
+ O -
] O +
exons O +
were O +
designated O +
as O +
ACEScan O -
[ O -
+ O -
] O +
compared O +
to O +
2.4 O -
% O +
( O -
2,328 O +
of O +
97,437 O -
) O +
of O +
REAP O -
[ O -
− O -
] O +
exons O -
. O +

This O +
result O +
suggested O +
that O +
a O +
small O +
but O +
significantly O +
enriched O +
fraction O +
of O +
AS O +
events O +
in O +
hESCs O +
versus O +
NPs O +
was O +
likely O +
to O +
be O +
evolutionarily O +
conserved O +
in O +
human B-Species +
and O +
mouse B-Species -
. O +

In O +
conclusion O -
, O +
our O +
results O +
suggested O +
that O +
REAP O +
predictions O +
were O +
congruent O +
with O +
predictions O +
from O +
two O +
independent O -
, O +
orthogonal O +
methods O -
. O +

Experimental O +
Validation O +
of O +
Alternative O +
ExonsThe O +
sensitivity O +
and O +
specificity O +
of O +
REAP O +
in O +
the O +
identification O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O +
was O +
tested O +
by O +
RT O -
- O -
PCR O -
. O +

To O +
validate O +
REAP O -
[ O -
+ O -
] O +
alternative O +
exons O -
, O +
RT O -
- O -
PCR O +
primers O +
were O +
designed O +
in O +
the O +
flanking O +
exons O +
to O +
amplify O +
both O +
isoforms O -
. O +

To O +
be O +
a O +
positively O +
validated O +
candidate O -
, O +
the O +
PCR O +
products O +
on O +
a O +
gel O +
had O +
to O +
satisfy O +
all O +
of O +
the O +
following O +
criteria O -
: O +
( O -
i O -
) O +
at O +
least O +
one O +
isoform O +
with O +
the O +
expected O +
size O +
must O +
be O +
visible O +
in O +
each O +
cell O +
type O -
; O +
( O -
ii O -
) O +
the O +
relative O +
abundance O +
of O +
the O +
two O +
isoforms O +
must O +
be O +
altered O +
between O +
two O +
cell O +
types O +
and O +
the O +
direction O +
of O +
change O +
have O +
to O +
be O +
consistent O +
with O +
the O +
REAP O +
studentized O +
residuals O -
: O +
in O +
our O +
study O +
positive O +
residuals O +
implied O +
inclusion O +
in O +
hESCs O +
and O +
skipping O +
in O +
NPs O -
, O +
and O +
negative O +
residuals O +
implied O +
inclusion O +
in O +
NP O +
and O +
skipping O +
in O +
hESCs O -
; O +
and O +
( O -
iii O -
) O +
the O +
results O +
were O +
replicable O +
in O +
at O +
least O +
two O +
experiments O -
. O +

For O +
simplicity O +
of O +
design O -
, O +
we O +
tested O +
candidates O +
predicted O +
from O +
Cyt O -
- O -
ES O +
versus O +
hCNS O -
- O -
SCns O -
. O +

Fifteen O +
REAP O -
[ O -
+ O -
] O +
exons O +
with O +
at O +
least O +
two O +
significant O +
outliers O +
( O -
out O +
of O +
five O -
) O +
were O +
randomly O +
chosen O +
as O +
predicted O +
alternative O +
events O +
and O +
thirty O -
- O -
five O +
exons O +
with O +
less O +
than O +
two O +
significant O +
outliers O +
were O +
randomly O +
chosen O +
as O +
constitutive O +
events O +
( O -
Table O +
S3 O -
) O -
. O +

Nine O +
of O +
the O +
fifteen O +
exons O +
( O -
60 O -
% O -
) O +
were O +
validated O +
as O +
AS O +
events O +
by O +
our O +
criteria O -
. O +

The O +
sensitivity O +
and O +
specificity O +
of O +
the O +
algorithm O +
at O +
the O +
cutoff O +
of O +
two O +
is O +
69 O -
% O +
and O +
77 O -
% O -
. O +

Increasing O +
the O +
cutoff O +
to O +
three O +
increased O +
the O +
specificity O +
to O +
85 O -
% O -
, O +
with O +
a O +
slight O +
decrease O +
in O +
sensitivity O +
to O +
67 O -
% O +
( O -
Figure O +
7A O -
) O -
. O +

The O +
patterns O +
of O +
AS O +
in O +
hESCs O +
were O +
similar O +
in O +
both O +
Cyt O -
- O -
ES O +
and O +
HUES6-ES O +
for O +
all O +
AS O +
events O +
validated O -
, O +
but O +
the O +
NPs O +
( O -
Cyt O -
- O -
NP O -
, O +
HUES6-NP O -
, O +
and O +
hCNS O -
- O -
SCns O -
) O +
had O +
more O +
varied O +
AS O -
. O +

The O +
pattern O +
of O +
AS O +
in O +
the O +
REAP O -
[ O -
+ O -
] O +
exons O +
in O +
the O +
SLK O +
( O -
serine O -
/ O -
threonine O +
kinase O +
2 O -
) O +
and O +
POT1 O +
( O -
protection O +
of O +
telomeres O +
1 O -
) O +
genes O +
showed O +
remarkable O +
agreement O +
within O +
derived O +
NPs O +
and O +
hCNS O -
- O -
SCns O +
( O -
Figure O +
7B O -
) O -
. O +

The O +
AS O +
exon O +
in O +
SLK O +
was O +
observed O +
to O +
be O +
included O +
in O +
hESCs O +
and O +
completely O +
excluded O +
in O +
NPs O -
; O +
the O +
AS O +
exon O +
in O +
the O +
POT1 O +
gene O +
was O +
included O +
more O +
in O +
hESCs O +
and O +
a O +
smaller O +
isoform O +
persisted O +
in O +
NPs O -
. O +

The O +
AS O +
patterns O +
of O +
the O +
other O +
verified O +
REAP O -
[ O -
+ O -
] O +
exons O +
were O +
consistently O +
similar O +
in O +
hESCs O +
but O +
were O +
more O +
varied O +
in O +
the O +
NP O -
. O +

Interestingly O -
, O +
the O +
patterns O +
of O +
AS O +
in O +
the O +
derived O +
NPs O +
( O -
Cyt O -
- O -
NP O +
and O +
HUES6-NP O -
) O +
were O +
not O +
always O +
identical O +
to O +
those O +
of O +
hCNS O -
- O -
SCns O -
. O +

For O +
example O -
, O +
the O +
AS O +
exon O +
in O +
the O +
EHBP1 O +
( O -
EH O +
domain O +
binding O +
protein O +
1 O -
) O +
gene O +
was O +
included O +
in O +
hESCs O +
but O +
skipped O +
in O +
hCNS O -
- O -
SCns O -
, O +
and O +
both O +
isoforms O +
were O +
present O +
in O +
the O +
derived O +
NPs O +
( O -
Figure O +
7B O -
) O -
. O +

As O +
another O +
example O -
, O +
the O +
AS O +
exon O +
in O +
the O +
SORBS1 O +
( O -
sorbin O +
and O +
SH3 O +
domain O +
containing O +
1 O -
) O +
gene O +
was O +
skipped O +
in O +
hESCs O +
and O +
included O +
in O +
hCNS O -
- O -
SCns O -
, O +
but O +
exhibited O +
an O +
intermediate O +
pattern O +
in O +
the O +
derived O +
NPs O -
. O +

However O -
, O +
in O +
some O +
cases O -
, O +
the O +
AS O +
patterns O +
in O +
the O +
derived O +
NPs O +
were O +
different O +
from O +
both O +
hESCs O +
and O +
hCNS O -
- O -
SCns O +
( O -
such O +
as O +
in O +
the O +
AS O +
exon O +
in O +
UNC84A O -
, O +
SIRT1 O -
, O +
and O +
MLLT10 O -
) O -
.Figure O +
7RT O -
- O -
PCR O +
Validation O +
of O +
REAP O -
- O -
Predicted O +
Alternative O +
Exons O -
( O -
A O -
) O +
Probesets O +
( O -
exons O -
) O +
were O +
considered O +
REAP O -
[ O -
+ O -
] O +
candidates O +
if O +
they O +
contained O +
at O +
least O +
N O +
= O +
2 O +
( O -
white O +
bars O -
) O -
, O +
3 O +
( O -
gray O +
bars O -
) O -
, O +
or O +
4 O +
( O -
black O +
bars O -
) O +
significant O +
outliers O -
. O +

True O +
positive O +
( O -
TP O -
) O -
, O +
true O +
negative O +
( O -
TN O -
) O -
, O +
false O +
positive O +
( O -
FP O -
) O -
, O +
and O +
false O +
negative O +
( O -
FN O -
) O +
rates O +
were O +
calculated O +
from O +
RT O -
- O -
PCR O -
- O -
validated O +
REAP O -
[ O -
+ O -
] O +
exons O +
at O +
the O +
different O +
cutoffs O +
( O -
N O +
= O +
2 O -
, O +
3 O -
, O +
4 O -
) O -
. O -
( O -
B O -
) O +
Nine O +
RT O -
- O -
PCR O +
validated O +
REAP O -
[ O -
+ O -
] O +
AS O +
events O +
in O +
hESCs O +
( O -
Cyt O -
- O -
ES O +
and O +
HUES6-ES O -
) O -
, O +
derived O +
NPs O +
( O -
Cyt O -
- O -
NP O +
and O +
HUES6-NP O -
) O -
, O +
and O +
hCNS O -
- O -
SCns O -
. O +

Arrows O +
indicate O +
the O +
larger O +
( O -
exon O -
- O -
included O -
) O +
isoforms O +
and O +
smaller O +
( O -
exon O -
- O -
skipped O -
) O +
isoforms. O -
( O -
C O -
) O +
RT O -
- O -
PCR O +
of O +
REAP O -
[ O -
+ O -
] O +
alternative O +
exons O +
from O +
EHBP1 O -
, O +
SLK O -
, O +
and O +
RAI14 O +
across O +
a O +
panel O +
of O +
human B-Species +
tissues O -
. O +

Arrows O +
indicate O +
the O +
larger O +
( O -
exon O -
- O -
included O -
) O +
isoforms O +
and O +
smaller O +
( O -
exon O -
- O -
skipped O -
) O +
isoforms O -
. O +

First O -
, O +
given O +
three O +
independent O +
samples O +
each O +
from O +
two O +
conditions O -
, O +
we O +
concluded O +
that O +
REAP O +
was O +
able O +
to O +
identify O +
AS O +
events O +
with O +
high O +
specificity O +
but O +
with O +
moderate O +
sensitivity O -
. O +

Second O -
, O +
AS O +
events O +
in O +
hESCs O +
were O +
more O +
similar O -
, O +
whereas O +
the O +
AS O +
events O +
in O +
derived O +
NPs O +
were O +
consistent O +
with O +
or O +
intermediate O +
to O +
the O +
benchmark O +
hCNS O -
- O -
SCns O -
, O +
likely O +
reflecting O +
differences O +
in O +
the O +
cell O +
lines O +
and/or O +
differentiation O +
protocols O -
. O +

In O +
addition O -
, O +
we O +
tested O +
the O +
AS O +
patterns O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O +
from O +
EHBP1 O -
, O +
SLK O -
, O +
and O +
RAI14 O +
in O +
a O +
panel O +
of O +
differentiated O +
human B-Species +
tissues O +
( O -
Figure O +
7C O -
) O -
. O +

The O +
REAP O -
[ O -
+ O -
] O +
alternative O +
exon O +
in O +
the O +
RAI14 O +
( O -
retinoic O +
acid O +
induced O +
14 O -
) O +
gene O +
was O +
observed O +
to O +
have O +
the O +
same O +
AS O +
pattern O +
in O +
NPs O +
as O +
in O +
frontal O +
and O +
temporal O +
cortex O +
and O +
in O +
several O +
other O -
, O +
non O -
- O -
brain O +
adult O +
tissues O -
, O +
such O +
as O +
heart O +
and O +
spleen O -
. O +

The O +
AS O +
pattern O +
of O +
the O +
REAP O -
[ O -
+ O -
] O +
exon O +
in O +
the O +
SLK O +
gene O +
in O +
NPs O +
was O +
similar O +
to O +
most O +
differentiated O +
tissues O -
; O +
however O -
, O +
the O +
relatively O +
strong O +
inclusion O +
of O +
the O +
exon O +
in O +
hESCs O +
was O +
unique O -
. O +

Even O +
in O +
esophagus O -
, O +
kidney O -
, O +
liver O -
, O +
and O +
prostate O -
, O +
both O +
isoforms O +
were O +
present O -
. O +

The O +
relative O +
ratio O +
of O +
the O +
exon O -
- O -
included O +
to O +
exon O -
- O -
skipped O +
isoforms O +
in O +
SLK O +
likely O +
represents O +
an O +
ESC O -
- O -
specific O +
AS O +
signature O -
. O +

The O +
alternative O +
exon O +
in O +
the O +
EHBP1 O +
gene O +
was O +
unusual O -
. O +

The O +
exon O +
was O +
included O +
in O +
hESCs O +
but O +
also O +
in O +
frontal O +
cortex O +
and O +
temporal O +
cortex O -
, O +
a O +
finding O +
that O +
was O +
unexpected O +
given O +
the O +
exclusion O +
of O +
the O +
exon O +
in O +
hCNS O -
- O -
SCns O +
( O -
Figure O +
7C O -
) O -
. O +

The O +
AS O +
pattern O +
in O +
hCNS O -
- O -
SCns O +
may O +
represent O +
a O +
transient O -
, O +
early O +
neuronal O +
molecular O +
change O -
. O +

Functional O +
and O +
Expression O +
Characteristics O +
of O +
REAP O -
[ O -
+ O -
] O +
GenesIn O +
total O -
, O +
1,500 O +
genes O +
were O +
identified O +
that O +
contained O +
1,737 O +
REAP O -
[ O -
+ O -
] O +
exons O -
, O +
68 O -
% O +
of O +
which O +
lacked O +
prior O +
transcript O +
( O -
EST O -
/ O -
cDNA O -
) O +
evidence O +
for O +
AS O -
. O +

To O +
determine O +
whether O +
genes O +
that O +
contained O +
REAP O -
[ O -
+ O -
] O +
exons O -
, O +
which O +
we O +
refer O +
to O +
as O +
REAP O -
[ O -
+ O -
] O +
genes O -
, O +
are O +
biased O +
toward O +
particular O +
biological O +
activities O -
, O +
REAP O -
[ O -
+ O -
] O +
genes O +
were O +
compared O +
to O +
a O +
set O +
of O +
REAP O +
analyzed O +
genes O +
not O +
found O +
to O +
have O +
REAP O -
[ O -
+ O -
] O +
exons O +
( O -
REAP O -
[ O -
− O -
] O +
genes O -
) O -
. O +

A O +
Gene O +
Ontology O +
analysis O +
revealed O +
that O +
REAP O -
[ O -
+ O -
] O +
genes O +
are O +
enriched O +
for O +
GO O +
molecular O +
function O +
categories O +
" O -
ATP O +
binding O -
, O -
" O +
" O -
helicase O +
activity O -
, O -
" O +
" O -
protein O +
serine O -
/ O -
theronine O +
kinase O +
activity O -
, O -
" O +
" O -
small O +
GTPase O +
regulatory O -
/ O -
interacting O +
protein O +
activity O -
, O -
" O +
and O +
" O -
thyroid O +
hormone O +
receptor O +
binding O -
" O +
( O -
Table O +
1 O -
) O -
. O +

In O +
terms O +
of O +
GO O +
biological O +
process O +
categories O -
, O +
REAP O -
[ O -
+ O -
] O +
genes O +
were O +
more O +
frequently O +
involved O +
in O +
" O -
ubiquitin O +
cycle O -
. O -
" O +

Similar O +
results O +
were O +
obtained O +
when O +
we O +
compared O +
REAP O -
[ O -
+ O -
] O +
genes O +
to O +
all O +
human B-Species +
genes O +
that O +
did O +
not O +
contain O +
REAP O -
[ O -
+ O -
] O +
exons O +
( O -
Table O +
1 O -
) O +
[ O -
55 O -
] O -
.Table O +
1Significantly O +
Enriched O +
Gene O +
Ontology O +
Terms O +
in O +
REAP O -
[ O -
+ O -
] O +
Genes O +
( O -
Cutoff O +
of O +
Two O +
Significant O +
" O -
Outliers O -
" O +
per O +
Probeset O -
) O -
Next O +
we O +
asked O +
if O +
REAP O -
[ O -
+ O -
] O +
genes O +
are O +
differentially O +
expressed O +
in O +
hESCs O +
compared O +
to O +
NPs O +
and O +
vice O +
versa O -
. O +

For O +
this O +
analysis O -
, O +
the O +
t O -
- O -
statistics O +
computed O +
above O +
measuring O +
the O +
enrichment O +
of O +
a O +
gene O +
in O +
hESCs O +
relative O +
to O +
NPs O +
was O +
utilized O +
for O +
only O +
REAP O -
- O -
analyzed O +
genes O -
. O +

At O +
a O +
defined O +
absolute O -
- O -
valued O +
cutoff O -
, O +
genes O +
were O +
divided O +
into O +
three O +
categories O -
: O +
" O -
enriched O +
in O +
hESCs O -
, O -
" O +
" O -
enriched O +
in O +
NP O -
, O -
" O +
or O +
" O -
unchanged O -
" O +
( O -
Figure O +
8A O -
) O -
. O +

Increasing O +
the O +
t O -
- O -
statistic O +
cutoff O +
from O +
one O +
to O +
five O -
, O +
the O +
fraction O +
of O +
REAP O -
[ O -
+ O -
] O +
genes O +
relative O +
to O +
REAP O -
- O -
analyzed O +
genes O +
remained O +
constant O +
in O +
the O +
" O -
unchanged O -
" O +
categories O +
( O -
Figure O +
8B O -
) O -
. O +

However O -
, O +
the O +
fraction O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O +
decreased O +
significantly O +
in O +
" O -
enriched O +
in O +
hESCs O -
" O +
and O +
" O -
enriched O +
in O +
NPs O -
" O +
categories O -
. O +

If O +
we O +
increased O +
the O +
cutoffs O +
on O +
genes O +
that O +
were O +
randomly O +
assigned O +
as O +
REAP O -
[ O -
+ O -
] O +
and O +
REAP O -
[ O -
− O -
] O -
, O +
controlling O +
for O +
the O +
same O +
number O +
of O +
genes O +
in O +
each O +
category O -
, O +
we O +
observed O +
that O +
the O +
fraction O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O +
remained O +
unchanged O +
for O +
all O +
three O +
categories O +
( O -
Figure O +
8C O -
) O -
. O +

To O +
illustrate O -
, O +
at O +
a O +
cutoff O +
of O +
five O -
, O +
10 O -
% O +
( O -
29 O +
of O +
267 O -
) O +
of O +
enriched O +
NP O +
genes O +
were O +
REAP O -
[ O -
+ O -
] O +
genes O +
and O +
8.8 O -
% O +
( O -
102 O +
of O +
1,162 O -
) O +
of O +
enriched O +
hESC O +
genes O +
were O +
REAP O -
[ O -
+ O -
] O -
, O +
significantly O +
different O +
( O -
p O +
< O +
0.000005 O -
) O +
from O +
the O +
random O +
control O +
where O +
∼14 O -
% O +
of O +
enriched O +
NP O +
and O +
enriched O +
hESC O +
genes O +
were O +
REAP O -
[ O -
+ O -
] O -
. O +

At O +
a O +
cutoff O +
of O +
five O -
, O +
14 O -
% O +
( O -
1,368 O +
of O +
9,636 O -
) O +
of O +
genes O +
that O +
were O +
expressed O +
at O +
similar O +
levels O +
between O +
hESCs O +
and O +
NPs O +
were O +
REAP O -
[ O -
+ O -
] O -
. O +

Our O +
results O +
suggested O +
that O +
a O +
strategy O +
of O +
focusing O +
on O +
differentially O +
expressed O +
genes O +
would O +
miss O +
at O +
least O +
14 O -
% O +
of O +
transcriptionally O +
unchanged O +
genes O +
that O +
may O +
nevertheless O +
have O +
functional O +
AS O +
differences O +
between O +
hESCs O +
and O +
NPs O -
. O +

Figure O +
8Analysis O +
of O +
REAP O -
[ O -
+ O -
] O +
Genes O +
Relative O +
to O +
Transcriptional O +
Differences O -
( O -
A O -
) O +
Histogam O +
of O +
t O -
- O -
statistics O +
computed O +
from O +
gene O -
- O -
level O +
signal O +
estimates O +
measuring O +
the O +
enrichment O +
of O +
genes O +
in O +
hESC O +
and O +
in O +
NP O -
. O +

Genes O +
on O +
the O +
right O +
of O +
the O +
vertical O +
line O +
at O +
5 O +
were O +
designated O +
enriched O +
in O +
hESC O +
and O +
genes O +
on O +
the O +
left O +
of O +
the O +
vertical O +
line O +
at O +
−5 O +
were O +
designated O +
enriched O +
in O +
NP O -
; O +
genes O +
in O +
between O +
−5 O +
and O +
5 O +
were O +
designated O +
as O +
" O -
unchanged O -
" O +
or O +
expressed O +
similarly O +
in O +
hESC O +
and O +
NP. O -
( O -
B O -
) O +
Vertical O +
bars O +
representing O +
the O +
percentage O +
of O +
REAP O -
[ O -
+ O -
] O +
genes O +
out O +
of O +
all O +
genes O +
in O +
the O +
different O +
classifications O +
( O -
dashed O +
bar O -
: O +
" O -
enriched O +
in O +
hESC O -
" O -
; O +
black O +
filled O +
bar O -
: O +
" O -
unchanged O -
" O -
; O +
white O +
filled O +
bar O -
: O +
" O -
enriched O +
in O +
NP O -
" O -
) O -
, O +
at O +
different O +
cutoffs O +
of O +
1 O +
to O +
5. O -
( O -
C O -
) O +
Set O +
of O +
genes O +
where O +
REAP O -
[ O -
+ O -
] O +
designation O +
was O +
randomly O +
chosen O -
. O +

Similar O +
representation O +
as O +
in O +
( O -
B O -
) O -
. O +

Conserved O +
Intronic O +
Splicing O +
Regulatory O +
Elements O +
Proximal O +
to O +
REAP O -
[ O -
+ O -
] O +
hESC O +
and O +
NP O +
ExonsMany O -
, O +
if O +
not O +
most O -
, O +
alternative O +
exons O +
undergo O +
cell O +
type O -
– O -
specific O +
regulation O +
by O +
the O +
binding O +
of O +
trans O -
- O -
factors O +
to O +
splicing O +
regulatory O +
cis O -
- O -
elements O +
located O +
proximal O +
to O +
or O +
within O +
the O +
exons O -
. O +

As O +
many O +
tissue O -
- O -
specific O +
splicing O +
cis O -
- O -
regulatory O +
elements O +
were O +
localized O +
in O +
intronic O +
regions O +
of O +
AS O +
exons O -
, O +
we O +
focused O +
on O +
the O +
identification O +
of O +
intronic O +
splicing O +
regulatory O +
elements O +
( O -
ISREs O -
) O +
proximal O +
to O +
REAP O -
[ O -
+ O -
] O +
exons O -
. O +

In O +
addition O -
, O +
we O +
wanted O +
to O +
identify O +
both O +
common O +
and O +
cell O +
type O -
– O -
specific O +
ISREs O -
. O +

Three O +
sets O +
of O +
exons O +
were O +
generated O -
: O +
( O -
i O -
) O +
REAP O -
[ O -
+ O -
] O +
exons O +
that O +
were O +
predicted O +
to O +
be O +
included O +
in O +
NPs O +
and O +
skipped O +
in O +
hESCs O +
( O -
REAP O -
[ O -
+ O -
] O -
NP O -
) O -
; O +
( O -
ii O -
) O +
REAP O -
[ O -
+ O -
] O +
exons O +
that O +
were O +
predicted O +
to O +
be O +
included O +
in O +
hESCs O +
and O +
skipped O +
in O +
NPs O +
( O -
REAP O -
[ O -
+ O -
] O -
hESC O -
) O -
; O +
and O +
( O -
iii O -
) O +
all O +
REAP O -
[ O -
− O -
] O +
exons O -
. O +

Regions O +
of O +
400 O +
base O +
pairs O +
flanking O +
the O +
exons O +
were O +
targeted O +
for O +
search O -
. O +

Initially O -
, O +
5-mers O +
that O +
were O +
significantly O +
enriched O +
between O +
the O +
upstream O +
and O +
downstream O +
intronic O +
regions O +
of O +
REAP O -
[ O -
+ O -
] O -
NP O +
and O +
REAP O -
[ O -
+ O -
] O -
ES O +
relative O +
to O +
REAP O -
[ O -
− O -
] O +
exons O +
were O +
enumerated O -
. O +

We O +
were O +
not O +
able O +
to O +
identify O +
5-mers O +
that O +
were O +
statistically O +
significantly O +
different O -
. O +

Next O -
, O +
we O +
focused O +
on O +
splicing O +
signals O +
that O +
were O +
conserved O +
across O +
mammalian O +
genomes O +
as O +
a O +
way O +
of O +
enhancing O +
the O +
signal O +
of O +
detecting O +
functional O +
splicing O +
regulatory O +
sequences O +
[ O -
66 O -
] O -
. O +

Exons O +
that O +
were O +
orthologous O +
across O +
human B-Species -
, O +
dog B-Species -
, O +
rat B-Species -
, O +
and O +
mouse B-Species +
were O +
obtained O +
and O +
the O +
flanking O +
intronic O +
regions O +
were O +
aligned O +
( O -
400 O +
bases O +
upstream O +
and O +
downstream O +
separately O -
; O +
Figure O +
9A O -
) O -
. O +

We O +
enumerated O +
k O -
- O -
mers O +
that O +
were O +
perfectly O +
conserved O +
across O +
all O +
four O +
genomes O +
in O +
the O +
upstream O +
( O -
and O +
downstream O -
) O +
intronic O +
regions O -
. O +

Each O +
conserved O +
k O -
- O -
mer O +
was O +
attributed O +
a O +
χ O +
score O +
representing O +
its O +
enrichment O +
in O +
a O +
set O +
of O +
exons O +
relative O +
to O +
another O +
set O +
of O +
exons O -
. O +

The O +
higher O +
the O +
score O -
, O +
the O +
more O +
frequent O +
the O +
conserved O +
k O -
- O -
mer O +
was O +
in O +
the O +
first O +
set O +
relative O +
to O +
the O +
second O +
set O -
. O +

As O +
a O +
negative O +
control O -
, O +
the O +
associations O +
between O +
REAP O +
scores O +
and O +
exons O +
were O +
shuffled O -
. O +

The O +
enrichment O +
scores O +
for O +
all O +
downstream O +
intronic O +
5-mers O +
for O +
shuffled O +
REAP O -
[ O -
+ O -
] O -
NP O +
versus O +
set O +
REAP O -
[ O -
− O -
] O +
exons O +
( O -
x O -
- O -
axis O -
) O -
, O +
and O +
for O +
shuffled O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons O +
versus O +
REAP O -
[ O -
− O -
] O +
exons O +
( O -
y O -
- O -
axis O -
) O +
were O +
displayed O +
( O -
Figure O +
9B O -
) O -
. O +

At O +
a O +
χ O +
cutoff O +
of O +
three O -
, O +
which O +
corresponded O +
to O +
a O +
p O -
- O -
value O +
of O +
0.0015 O -
, O +
the O +
majority O +
of O +
5-mers O +
were O +
not O +
significantly O +
enriched O +
in O +
either O +
shuffled O +
set O -
. O +

Confident O +
that O +
no O +
association O +
of O +
k O -
- O -
mers O +
with O +
shuffled O +
REAP O +
exons O +
were O +
found O -
; O +
we O +
repeated O +
the O +
analyses O +
for O +
upstream O +
and O +
downstream O +
intronic O +
5-mers O +
for O +
the O +
original O +
unshuffled O +
sets O -
. O +

We O +
identified O +
68 O +
conserved O +
5-mers O +
enriched O +
upstream O +
of O +
REAP O -
[ O -
+ O -
] O -
NP O +
exons O -
; O +
and O +
34 O +
5-mers O +
enriched O +
upstream O +
of O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons O +
( O -
Figure O +
9C O -
; O +
Table O +
S4 O -
) O -
. O +

Of O +
the O +
5-mers O +
that O +
were O +
significantly O +
enriched O +
upstream O +
of O +
REAP O -
[ O -
+ O -
] O -
NP O +
exons O -
, O +
we O +
identified O +
a O +
U O -
- O -
rich O +
motif O +
( O -
UUUUU O -
) O -
, O +
a O +
GU O -
- O -
rich O +
motif O +
( O -
GUGUG O -
) O -
, O +
and O +
a O +
CU O -
- O -
rich O +
motif O +
( O -
CCUCU O -
, O +
CUCUC O -
, O +
UCUCU O -
, O +
GCUCU O -
) O -
. O +

It O +
is O +
known O +
that O +
the O +
heterogeneous O +
ribonucleoprotein O +
C O +
( O -
hnRNP O +
C O -
) O +
binding O +
site O +
obtained O +
by O +
SELEX O +
is O +
five O +
" O -
U"s O +
[ O -
67 O -
] O -
. O +

GU O -
- O -
rich O +
sequences O +
in O +
flanking O +
intronic O +
regions O +
were O +
shown O +
to O +
bind O +
to O +
splicing O +
factor O +
ETR-3 O +
to O +
regulate O +
AS O +
[ O -
68 O -
] O -
. O +

CU O -
- O -
rich O +
sequences O +
were O +
shown O +
to O +
bind O +
the O +
splicing O +
factor O +
PTB O +
[ O -
69 O -
] O -
. O +

Of O +
the O +
5-mers O +
enriched O +
upstream O +
of O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons O -
, O +
we O +
observed O +
CUAAC O -
, O +
which O +
resembled O +
the O +
splicing O +
branch O -
- O -
signal O -
. O +

Of O +
the O +
six O +
5-mers O +
that O +
were O +
enriched O +
upstream O +
of O +
both O +
REAP O -
[ O -
+ O -
] O -
NP O +
and O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons O -
, O +
we O +
identified O +
GCAUG O -
, O +
which O +
was O +
previously O +
shown O +
to O +
be O +
an O +
intronic O +
splicing O +
cis O -
- O -
element O +
for O +
the O +
mammalian O +
fibronectin O +
and O +
calcitonin O -
/ O -
CGRP O +
genes O +
[ O -
70–72 O -
] O -
. O +

More O +
recently O -
, O +
both O +
mammalian O +
Fox1 O +
and O +
2 O +
have O +
been O +
demonstrated O +
to O +
regulate O +
alternatively O +
spliced O +
exons O +
via O +
UGCAUG O +
binding O +
sites O +
in O +
neighboring O +
introns O +
in O +
neuronal O +
cell O +
cultures O +
[ O -
73 O -
] O -
.Figure O +
9Conserved O +
Intronic O +
cis O -
- O -
Elements O +
Enriched O +
Proximal O +
to O +
REAP O -
[ O -
+ O -
] O +
Alternative O +
Exons O -
( O -
A O -
) O +
Schematic O +
describing O +
the O +
enumeration O +
of O +
intronic O +
elements O +
across O +
400 O +
bases O +
of O +
flanking O +
mammalian O +
introns O +
( O -
human B-Species -
, O +
dog B-Species -
, O +
rat B-Species -
, O +
and O +
mouse B-Species -
) O -
. O +

Red O +
and O +
green O +
horizontal O +
bars O +
represent O +
conserved O +
intronic O +
elements O +
and O +
nonconserved O +
elements O -
, O +
respectively O -
. O +

Internal O +
exons O +
were O +
divided O +
into O +
REAP O -
[ O -
+ O -
] O -
NP O -
, O +
REAP O -
[ O -
+ O -
] O -
ES O -
, O +
and O +
REAP O -
[ O -
− O -
] O +
exons O -
. O +

The O +
χ O +
statistic O +
was O +
computed O +
to O +
represent O +
the O +
enrichment O +
of O +
conserved O +
elements O +
in O +
intronic O +
regions O +
flanking O +
REAP O -
[ O -
+ O -
] O -
NP O +
versus O +
REAP O -
[ O -
− O -
] O +
exons O +
( O -
x O -
- O -
axis O -
) O -
, O +
and O +
REAP O -
[ O -
+ O -
] O -
ES O +
versus O +
REAP O -
[ O -
− O -
] O +
exons O +
( O -
y O -
- O -
axis O -
) O -
. O +

The O +
sign O +
represented O +
the O +
direction O +
of O +
change O -
, O +
i.e. O -
, O +
positive O +
if O +
enriched O +
in O +
introns O +
flanking O +
REAP O -
[ O -
+ O -
] O +
versus O +
REAP O -
[ O -
− O -
] O +
exon O -
. O +

Each O +
conserved O +
5-mer O +
was O +
associated O +
with O +
two O +
numbers O -
: O +
the O +
enrichment O +
in O +
introns O +
proximal O +
to O +
REAP O -
[ O -
+ O -
] O -
NP O +
versus O +
REAP O -
[ O -
− O -
] O +
exons O +
( O -
x O -
- O -
axis O -
) O -
, O +
and O +
REAP O -
[ O -
+ O -
] O -
ES O +
versus O +
REAP O -
[ O -
− O -
] O +
exons O +
( O -
y O -
- O -
axis O -
) O -
. O -
( O -
B O -
) O +
Downstream O +
intronic O +
regions O -
, O +
where O +
the O +
association O +
between O +
REAP O -
[ O -
+ O -
] O +
designation O +
and O +
the O +
exons O +
was O +
shuffled. O -
( O -
C O -
) O +
Upstream O +
intronic O +
regions O -
. O +

Circled O +
5-mers O +
in O +
the O +
upper O +
right O +
quadrant O +
represent O +
conserved O +
5-mers O +
enriched O +
in O +
the O +
upstream O +
intronic O +
regions O +
of O +
REAP O -
[ O -
+ O -
] O -
NP O +
and O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons. O -
( O -
D O -
) O +

Downstream O +
intronic O +
regions O -
. O +

Circled O +
5-mers O +
in O +
the O +
upper O +
right O +
quadrant O +
represent O +
conserved O +
5-mers O +
enriched O +
in O +
the O +
downstream O +
intronic O +
regions O +
of O +
REAP O -
[ O -
+ O -
] O -
NP O +
and O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons O -
. O +

Eighteen O +
conserved O +
5-mers O +
were O +
significantly O +
enriched O +
in O +
the O +
downstream O +
introns O +
of O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons O -
; O +
and O +
76 O +
5-mers O +
were O +
enriched O +
downstream O +
of O +
REAP O -
[ O -
+ O -
] O -
NP O +
exons O +
( O -
Table O +
S4 O -
, O +
Figure O +
9D O -
) O -
. O +

We O +
identified O +
a O +
motif O +
CUCAU O +
resembling O +
the O +
Nova O +
binding O +
site O +
YCAY O +
[ O -
74 O -
] O -
, O +
and O +
a O +
G O -
- O -
rich O +
motif O +
( O -
AGGGG O -
, O +
GGGGA O -
, O +
GGGGC O -
, O +
GGGGG O -
, O +
GGGGU O -
) O +
enriched O +
in O +
the O +
introns O +
downstream O +
of O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons O -
. O +

G O -
- O -
rich O +
motifs O +
had O +
previously O +
been O +
shown O +
to O +
be O +
part O +
of O +
a O +
bipartite O +
signal O +
that O +
silences O +
AS O +
exons O +
[ O -
75 O -
] O -
. O +

Of O +
the O +
five O +
5-mers O +
that O +
were O +
enriched O +
downstream O +
of O +
both O +
REAP O -
[ O -
+ O -
] O -
NP O +
and O +
REAP O -
[ O -
+ O -
] O -
ES O +
exons O -
, O +
GCAUG O +
and O +
a O +
U O -
- O -
rich O +
motif O +
( O -
UUUUU O -
) O +
were O +
identified O -
. O +

We O +
concluded O +
that O +
potential O +
ISREs O +
were O +
enriched O +
proximal O +
to O +
a O +
subset O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O -
; O +
in O +
particular O -
, O +
the O +
Fox1 O -
/ O -
2 O +
binding O +
site O +
GCUAG O +
may O +
play O +
a O +
regulatory O +
role O +
in O +
controlling O +
AS O +
events O +
in O +
hESCs O +
and O +
NPs O -
. O +

The O +
ability O +
of O +
ESCs O +
to O +
generate O +
all O +
three O +
embryonic O +
germ O +
layers O +
has O +
raised O +
the O +
exciting O +
possibility O +
that O +
hESCs O +
may O +
become O +
an O +
unlimited O +
source O +
of O +
cells O +
for O +
transplantation O +
therapies O +
involving O +
organs O +
or O +
tissues O +
such O +
as O +
the O +
liver O -
, O +
pancreas O -
, O +
blood O -
, O +
and O +
nervous O +
system O -
, O +
and O +
become O +
tools O +
to O +
explore O +
the O +
molecular O +
mechanisms O +
of O +
human B-Species +
development O -
. O +

Despite O +
such O +
interests O -
, O +
relatively O +
little O +
is O +
understood O +
about O +
the O +
molecular O +
mechanisms O +
defining O +
their O +
pluripotency O +
and O +
the O +
molecular O +
changes O +
important O +
for O +
hESCs O +
to O +
differentiate O +
into O +
specific O +
cell O +
types O -
. O +

To O +
understand O +
these O +
events O -
, O +
protocols O +
are O +
still O +
being O +
developed O +
to O +
differentiate O +
ESCs O +
into O +
a O +
variety O +
of O +
lineages O -
. O +

Of O +
particular O +
biomedical O +
interest O +
is O +
in O +
the O +
capacity O +
of O +
hESCs O +
to O +
be O +
differentiated O +
into O +
a O +
self O -
- O -
renewing O +
population O +
of O +
NPs O +
that O +
can O +
be O +
then O +
further O +
coaxed O +
into O +
a O +
variety O +
of O +
neuronal O +
subtypes O -
, O +
such O +
as O +
dopaminergic O +
neurons O +
that O +
are O +
important O +
in O +
the O +
treatment O +
of O +
Parkinson O +
disease O +
or O +
cholinergic O +
neurons O +
for O +
ALS O +
( O -
amyotrophic O +
lateral O +
sclerosis O -
) O -
. O +

While O +
many O +
microarray O +
studies O +
have O +
explored O +
molecular O +
differences O +
between O +
hESCs O +
and O +
derived O +
NPs O -
, O +
most O -
, O +
if O +
not O +
all O -
, O +
have O +
focused O +
on O +
transcriptional O +
changes O -
. O +

These O +
studies O +
have O +
largely O +
ignored O +
intermediate O +
RNA O +
processing O +
events O +
prior O +
to O +
and O +
during O +
translation O -
. O +

In O +
recent O +
years O -
, O +
AS O +
has O +
gained O +
momentum O +
as O +
being O +
important O +
in O +
development O -
, O +
apoptosis O -
, O +
and O +
cancer O -
. O +

REAP O -
, O +
a O +
regression O -
- O -
based O +
method O +
for O +
analyzing O +
exon O +
array O +
data O +
was O +
introduced O -
, O +
and O +
was O +
applied O +
to O +
discover O +
AS O +
events O +
in O +
hESCs O -
, O +
their O +
derived O +
NPs O -
, O +
and O +
in O +
hCNS O -
- O -
SCns O -
. O +

REAP O +
was O +
based O +
on O +
the O +
assumptions O +
that O +
most O +
exons O +
in O +
the O +
gene O +
of O +
interest O +
and O +
in O +
the O +
genome O +
are O +
constitutively O +
spliced O +
and O +
that O +
outliers O +
in O +
a O +
linear O +
pairwise O +
comparison O +
of O +
the O +
signal O +
estimates O +
for O +
probesets O +
in O +
a O +
gene O +
could O +
be O +
detected O +
using O +
a O +
robust O +
regression O -
- O -
based O +
approach O -
. O +

REAP O +
predictions O +
were O +
found O +
to O +
correlate O +
well O +
with O +
transcript O -
- O -
based O +
methods O +
for O +
identifying O +
alternative O +
exons O -
, O +
which O +
interestingly O +
suggested O +
that O +
current O +
databases O +
of O +
transcript O +
information O -
, O +
albeit O +
not O +
specifically O +
enriched O +
for O +
hESC O +
or O +
NPs O -
, O +
in O +
aggregate O +
are O +
nevertheless O +
predictive O +
of O +
AS O +
events O +
in O +
hESC O +
and O +
NP O -
. O +

In O +
addition O -
, O +
REAP O -
[ O -
+ O -
] O +
exons O +
were O +
also O +
enriched O +
for O +
ACEScan O -
- O -
predicted O +
evolutionarily O +
conserved O +
exons O +
[ O -
55 O -
] O -
. O +

As O +
ACEScan O +
utilized O +
a O +
different O +
set O +
of O +
information O +
from O +
REAP O -
, O +
the O +
agreement O +
between O +
both O +
algorithms O +
served O +
to O +
further O +
validate O +
the O +
predicted O +
alternative O +
exons O -
. O +

Additional O +
studies O +
in O +
mouse B-Species +
ESCs O +
and O +
neural O +
derivatives O +
will O +
be O +
necessary O +
to O +
determine O +
if O +
these O +
AS O +
events O +
are O +
indeed O +
preserved O +
in O +
these O +
analogous O +
and O +
orthologous O +
cell O +
types O -
. O +

Our O +
finding O +
that O +
only O +
a O +
minority O +
of O +
AS O +
events O +
was O +
common O +
between O +
various O +
hESC O +
to O +
NP O +
comparisons O +
is O +
intriguing O -
. O +

A O +
possible O +
explanation O +
is O +
that O +
the O +
cell O +
lines O +
were O +
not O +
only O +
genetically O +
different O -
, O +
but O +
were O +
also O +
exposed O +
to O +
different O +
isolation O +
and O +
culture O +
conditions O -
. O +

In O +
addition O -
, O +
the O +
different O +
differentiation O +
protocols O +
established O +
as O +
optimal O +
for O +
generating O +
Nestin O +
and O +
Sox1 O +
positive O +
neural O +
precursors O +
may O +
lead O +
to O +
vastly O +
different O +
molecular O +
changes O -
. O +

It O +
is O +
likely O +
that O +
post O -
- O -
transcriptional O +
changes O +
such O +
as O +
AS O +
may O +
be O +
more O +
variable O +
despite O +
the O +
cells O +
being O +
at O +
acknowledged O +
" O -
end O -
- O -
points O -
" O +
defined O +
by O +
a O +
limited O +
set O +
of O +
immunohistochemical O +
markers O -
. O +

Our O +
results O +
are O +
consistent O +
with O +
a O +
recent O +
study O +
that O +
showed O +
that O +
while O +
two O +
well O -
- O -
established O +
hESC O +
lines O +
differentiate O +
into O +
functional O +
neurons O -
, O +
the O +
two O +
lines O +
exhibited O +
distinct O +
differentiation O +
potentials O -
, O +
suggesting O +
that O +
some O +
preprogramming O +
had O +
occurred O +
[ O -
76 O -
] O -
. O +

In O +
particular O -
, O +
microRNA O +
profiling O +
revealed O +
significant O +
expression O +
differences O +
between O +
the O +
two O +
hESC O +
lines O -
, O +
suggesting O +
that O +
microRNAs O -
, O +
known O +
post O -
- O -
transcriptional O +
regulators O -
, O +
may O +
sway O +
the O +
differentiation O +
properties O +
of O +
the O +
cell O +
lines O +
[ O -
76 O -
] O -
. O +

We O +
postulated O +
that O +
AS O +
events O +
may O +
serve O +
also O +
to O +
bias O +
the O +
differentiation O +
spectrum O +
of O +
the O +
cells O -
, O +
an O +
important O +
avenue O +
for O +
future O +
work O -
. O +

Experimental O +
validation O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O +
suggested O +
a O +
high O +
specificity O +
at O +
the O +
expense O +
of O +
relatively O +
moderate O +
sensitivity O -
. O +

We O +
believe O +
that O +
the O +
high O +
FP O +
rates O +
may O +
arise O +
from O +
cross O -
- O -
hybridization O +
effects O +
that O +
remained O +
unaccounted O +
for O -
. O +

However O -
, O +
our O +
specificity O +
of O +
77 O -
% O +
at O +
the O +
cutoff O +
of O +
two O +
significant O +
outliers O +
per O +
probeset O +
allowed O +
us O +
to O +
estimate O +
that O +
at O +
least O +
1,336 O +
of O +
1,737 O +
REAP O -
[ O -
+ O -
] O +
exons O +
were O +
true O +
AS O +
events O +
that O +
changed O +
during O +
neuronal O +
differentiation O +
of O +
hESC O +
cells O -
, O +
and/or O +
were O +
different O +
between O +
endogeneous O +
NPs O +
and O +
hESC O -
. O +

On O +
average O -
, O +
7 O -
% O +
of O +
all O +
human B-Species +
exons O +
have O +
been O +
estimated O +
by O +
transcript O +
data O +
to O +
undergo O +
AS O -
; O +
thus O +
REAP O -
's O +
validation O +
rate O +
of O +
60 O -
% O +
at O +
the O +
cutoff O +
of O +
two O +
is O +
73-fold O +
( O -
60 O -
/ O -
7 O -
) O +
higher O +
than O +
expected O -
. O +

In O +
addition O -
, O +
we O +
validated O +
nine O +
novel O +
AS O +
events O +
that O +
distinguish O +
hESCs O +
and O +
NPs O -
. O +

Consistent O +
with O +
our O +
computational O +
results O -
, O +
we O +
observed O +
that O +
the O +
AS O +
patterns O +
in O +
hCNS O -
- O -
SCns O +
were O +
not O +
always O +
similar O +
to O +
those O +
of O +
the O +
derived O +
NPs O -
. O +

It O +
was O +
important O +
to O +
point O +
out O +
that O +
while O +
transcriptional O +
expression O +
of O +
these O +
genes O +
did O +
not O +
distinguish O +
these O +
cells O +
from O +
one O +
another O -
, O +
in O +
several O +
instances O +
the O +
REAP O -
- O -
predicted O +
AS O +
event O +
was O +
able O +
to O +
separate O +
derived O +
NPs O +
and O +
hCNS O -
- O -
SCns O -
. O +

A O +
notable O +
exception O +
was O +
the O +
alternative O +
exon O +
in O +
the O +
SLK O +
gene O -
, O +
encoding O +
a O +
serine O -
/ O -
threonine O +
kinase O +
protein O -
, O +
which O +
was O +
commonly O +
included O +
in O +
both O +
hESCs O -
, O +
i.e. O -
, O +
the O +
exon O -
- O -
excluded O +
isoform O +
was O +
not O +
present O +
in O +
hESCs O +
compared O +
to O +
NPs O -
, O +
as O +
well O +
as O +
in O +
a O +
variety O +
of O +
differentiated O +
tissues O -
. O +

Closer O +
inspection O +
of O +
the O +
REAP O -
[ O -
+ O -
] O -
-validated O +
AS O +
exon O +
in O +
the O +
SLK O +
gene O +
revealed O +
strong O +
conservation O +
in O +
the O +
intronic O +
region O +
flanking O +
the O +
exon O -
, O +
a O +
hallmark O +
feature O +
of O +
evolutionarily O +
conserved O +
AS O +
exons O +
[ O -
55,77,78 O -
] O -
. O +

A O +
study O +
analyzing O +
the O +
expression O +
patterns O +
of O +
the O +
SLK O +
gene O +
suggested O +
a O +
potential O +
functional O +
role O +
during O +
embryonic O +
development O +
and O +
in O +
the O +
adult O +
central O +
nervous O +
system O +
[ O -
79 O -
] O -
; O +
however O -
, O +
to O +
our O +
knowledge O -
, O +
our O +
identification O +
of O +
the O +
SLK O +
alternative O +
exon O +
is O +
the O +
first O +
report O +
of O +
a O +
hESC O -
- O -
biased O +
AS O +
pattern O +
during O +
neuronal O +
differentiation O +
and O +
across O +
a O +
myriad O +
of O +
differentiated O +
tissues O -
. O +

In O +
agreement O -
, O +
GO O +
analysis O +
suggested O +
that O +
genes O +
containing O +
REAP O -
[ O -
+ O -
] O +
exons O +
were O +
enriched O +
in O +
serine O -
/ O -
threonine O +
kinase O +
activity O -
, O +
of O +
which O +
SLK O +
is O +
a O +
family O +
member O -
. O +

Future O +
work O +
will O +
be O +
required O +
to O +
study O +
the O +
impact O +
of O +
AS O +
in O +
these O +
genes O +
in O +
hESCs O +
and O +
NPs O -
. O +

We O +
predict O +
it O +
is O +
unlikely O +
that O +
the O +
alternative O +
exon O +
in O +
the O +
SLK O +
gene O +
is O +
the O +
only O +
case O +
common O +
across O +
hESC O +
and O +
different O +
from O +
differentiated O +
tissues O -
, O +
but O +
further O +
studies O +
will O +
be O +
necessary O +
to O +
identify O +
other O +
hESC O -
- O -
specific O +
exons O -
. O +

REAP O -
[ O -
+ O -
] O +
exons O +
were O +
underrepresented O +
in O +
genes O +
that O +
were O +
differentially O +
transcriptionally O +
regulated O +
in O +
hESCs O +
and O +
NPs O -
. O +

Our O +
results O +
act O +
as O +
a O +
reminder O +
that O +
focusing O +
only O +
on O +
genes O +
that O +
are O +
differentially O +
expressed O +
will O +
overlook O +
RNA O +
processing O +
events O +
that O +
may O +
be O +
biologically O +
relevant O +
to O +
the O +
system O +
of O +
interest O -
. O +

Finally O -
, O +
we O +
identified O +
potential O +
cis O -
- O -
regulatory O +
intronic O +
elements O +
conserved O +
and O +
enriched O +
proximal O +
to O +
the O +
REAP O -
[ O -
+ O -
] O +
exons O -
. O +

In O +
particular O -
, O +
the O +
FOX1 O -
/ O -
2 O +
binding O +
site O -
, O +
GCUAG O -
, O +
was O +
conserved O +
and O +
enriched O +
in O +
the O +
flanking O +
introns O +
of O +
a O +
subset O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O -
. O +

Further O +
studies O +
will O +
be O +
required O +
to O +
explore O +
the O +
importance O +
of O +
FOX1 O +
family O +
members O +
in O +
early O +
neuronal O +
differentiation O -
. O +

In O +
conclusion O -
, O +
our O +
introduction O +
of O +
REAP O +
and O +
its O +
application O +
to O +
identifying O +
AS O +
events O +
has O +
revealed O +
new O +
and O +
unanticipated O +
insights O +
into O +
hESC O +
biology O +
and O +
their O +
transition O +
to O +
NP O +
cells O -
. O +

Collectively O -
, O +
these O +
exons O +
represent O +
a O +
set O +
of O +
molecular O +
changes O +
that O +
are O +
likely O +
to O +
be O +
important O +
for O +
studying O +
human B-Species +
neural O +
differentiation O +
with O +
applications O +
in O +
neuronal O +
regenerative O +
medicine O -
. O +

Maintenance O +
and O +
differentiation O +
of O +
hESCs O +
and O +
hCNS O -
- O -
SCns.hESC O +
line O +
Cy203 O +
( O -
Cythera O -
) O +
was O +
cultured O +
as O +
previously O +
described O +
[ O -
12 O -
] O -
. O +

To O +
differentiate O +
into O +
neuroepithelial O +
precursor O +
cells O -
, O +
colonies O +
were O +
manually O +
isolated O +
from O +
mouse B-Species +
embryonic O +
fibroblasts O +
( O -
MEFs O -
) O +
and O +
cut O +
in O +
small O +
pieces O -
. O +

These O +
pieces O +
were O +
transferred O +
to O +
a O +
T75 O +
flask O +
with O +
hESCs O +
differentiation O +
media O +
( O -
same O +
hESC O +
medium O +
but O +
10 O -
% O +
KSR O +
and O +
no O +
FGF-2 O -
) O -
. O +

Medium O +
was O +
changed O +
the O +
next O +
day O +
by O +
transferring O +
the O +
floating O +
hESC O +
aggregates O +
to O +
a O +
new O +
flask O -
. O +

After O +
culturing O +
for O +
a O +
week O -
, O +
the O +
hESC O +
cell O +
aggregates O +
formed O +
mature O +
embroid O +
bodies O +
( O -
EBs O -
; O +
∼10 O +
um O +
round O +
clusters O +
with O +
dark O +
centers O -
) O -
. O +

EBs O +
were O +
plated O +
on O +
a O +
coated O +
10-cm O +
dish O +
in O +
hESC O +
differentiation O +
media O -
. O +

The O +
next O +
day O -
, O +
the O +
medium O +
was O +
changed O +
to O +
DMEM O -
/ O -
F12 O +
supplemented O +
with O +
ITS O +
and O +
fibronectin O -
. O +

Medium O +
was O +
changed O +
every O +
other O +
day O +
for O +
a O +
week O +
or O +
until O +
the O +
cells O +
formed O +
rosette O -
- O -
like O +
columnar O +
structures O +
that O +
were O +
isolated O +
manually O -
. O +

These O +
structures O +
were O +
then O +
transferred O +
to O +
coated O +
dishes O +
in O +
neural O +
induction O +
medium O +
( O -
DMEM O -
/ O -
F12 O +
supplemented O +
with O +
N2 O +
and O +
FGF-2 O -
) O +
for O +
a O +
week O -
. O +

Elongated O +
single O +
cells O +
were O +
separated O +
from O +
leftover O +
aggregates O +
using O +
non O -
- O -
enzymatic O +
dissociation O -
. O +

After O +
one O +
to O +
two O +
passages O -
, O +
the O +
cells O +
formed O +
a O +
monolayer O +
of O +
homogeneous O +
NPs O +
( O -
negative O +
for O +
Sox1 O +
immunostaining O -
) O -
. O +

Upon O +
confluence O -
, O +
cells O +
will O +
form O +
neurospheres O +
that O +
can O +
also O +
be O +
isolated O +
from O +
the O +
neuroepithelial O +
precursor O +
cells O +
( O -
positive O +
for O +
Sox1 O +
immunostaining O -
) O -
. O +

At O +
any O +
of O +
these O +
two O +
stages O -
, O +
pan O -
- O -
neuronal O +
differentiation O +
can O +
be O +
achieved O +
after O +
three O +
to O +
four O +
weeks O -
. O +

hESC O +
line O +
HUES6 O +
was O +
cultured O +
on O +
MEF O +
feeders O +
as O +
previously O +
described O +
( O -
http://www.mcb.harvard.edu/melton/hues/ O -
) O +
or O +
on O +
GFR O +
matrigel O +
coated O +
plates O -
. O +

Cells O +
grown O +
on O +
matrigel O +
were O +
grown O +
in O +
MEF O -
- O -
conditioned O +
medium O +
and O +
FGF-2 O +
was O +
used O +
at O +
20 O +
ng O -
/ O -
mL O +
instead O +
of O +
10 O +
ng O -
/ O -
mL O +
for O +
cells O +
grown O +
on O +
MEFs O -
. O +

To O +
differentiate O +
neuroepithelial O +
precursors O -
, O +
colonies O +
were O +
removed O +
by O +
treatment O +
with O +
collagenase O +
IV O +
( O -
Sigma O -
) O +
and O +
washed O +
three O +
times O +
in O +
growth O +
media O -
. O +

The O +
pieces O +
of O +
colonies O +
were O +
resuspended O +
in O +
HUES O +
growth O +
media O +
without O +
FGF2 O +
in O +
an O +
uncoated O +
bacterial O +
Petri O +
dish O +
to O +
form O +
EBs O -
. O +

After O +
one O +
week O -
, O +
EBs O +
were O +
plated O +
on O +
polyornathine O -
/ O -
laminin O +
coated O +
plates O +
in O +
DMEM O -
/ O -
F12 O +
supplemented O +
with O +
N2 O +
and O +
FGF2 O -
. O +

Rosette O +
structures O +
were O +
manually O +
collected O +
and O +
enzymatically O +
dissociated O +
with O +
TryPLE O +
( O -
Invitrogen O -
) O -
, O +
plated O +
on O +
polyornathine O -
/ O -
laminin O +
coated O +
plates O -
, O +
and O +
grown O +
in O +
DMEM O -
/ O -
F12 O +
supplemented O +
with O +
N2 O +
and O +
B27-RA O +
and O +
20 O +
ng O -
/ O -
mL O +
FGF-2 O -
. O +

Cells O +
could O +
be O +
grown O +
as O +
a O +
monolayer O +
for O +
up O +
to O +
at O +
least O +
ten O +
passages O -
. O +

Cells O +
were O +
Sox1 O +
and O +
nestin O +
positive O +
and O +
readily O +
differentiated O +
into O +
neurons O +
upon O +
withdrawal O +
of O +
FGF-2 O -
. O +

Human B-Species +
central O +
nervous O +
system O +
stem O +
cell O +
line O +
FBR1664 O +
( O -
StemCells O -
) O +
which O +
is O +
referred O +
to O +
as O +
hCNS O -
- O -
SCns O +
in O +
the O +
main O +
text O +
was O +
cultured O +
as O +
previously O +
described O +
[ O -
23 O -
] O -
. O +

The O +
cells O +
were O +
cultured O +
in O +
medium O +
consisting O +
of O +
Ex O +
Vivo O +
15 O +
( O -
BioWhittaker O -
) O +
medium O +
with O +
N2 O +
supplement O +
( O -
GIBCO O -
) O -
, O +
FGF2 O +
( O -
20 O +
ng O -
/ O -
mL O -
) O -
, O +
epidermal O +
growth O +
factor O +
( O -
20 O +
ng O -
/ O -
mL O -
) O -
, O +
lymphocyte O +
inhibitory O +
factor O +
( O -
10 O +
ng O -
/ O -
mL O -
) O -
, O +
0.2 O +
mg O -
/ O -
ml O +
heparin O -
, O +
and O +
60 O +
ug O -
/ O -
mL O +
N O -
- O -
acetylcysteine O -
. O +

Cultures O +
were O +
fed O +
weekly O +
and O +
passaged O +
at O +
∼two O +
to O +
three O +
weeks O +
using O +
collagenases O +
( O -
Roche O -
) O -
. O +

The O +
following O +
antibodies O +
and O +
corresponding O +
dilutions O +
were O +
utilized O +
for O +
the O +
immunohistochemical O +
analysis O +
of O +
marker O +
genes O +
in O +
Cyt O -
- O -
ES O +
and O +
HUES6-ES O -
: O +
Sox2 O +
( O -
Chemicon O -
, O +
1:500 O -
) O -
, O +
Oct4 O +
( O -
Santa O +
Cruz O -
, O +
1:500 O -
) O -
, O +
Sox1 O +
( O -
Chemicon O -
, O +
1:500 O -
) O -
, O +
Nestin O +
( O -
Pharmingen O -
, O +
1:250 O -
) O -
; O +
hCNS O -
- O -
SCns O -
: O +
Sox2 O +
( O -
Chemicon O -
, O +
1:200 O -
) O -
, O +
Nestin O +
( O -
Chemicon O -
, O +
1:200 O -
) O -
. O +

RNA O +
preparation O +
and O +
array O +
hybridization O -
. O +

Total O +
RNA O +
from O +
cells O +
was O +
processed O +
as O +
follows O -
. O +

Cells O +
were O +
lysed O +
in O +
1 O +
mL O +
of O +
RNA O -
- O -
bee O +
( O -
Teltest O -
) O -
. O +

The O +
RNA O +
was O +
isolated O +
by O +
chloroform O +
extraction O +
of O +
the O +
aqueous O +
phase O -
, O +
followed O +
by O +
isopropanol O +
precipitation O +
as O +
per O +
the O +
manufacturer O -
's O +
instructions O -
. O +

The O +
precipitated O +
RNA O +
was O +
washed O +
in O +
75 O -
% O +
ethanol O +
and O +
eluted O +
with O +
DEPC O -
- O -
treated O +
water O -
. O +

Five O +
ug O +
of O +
RNA O +
was O +
treated O +
with O +
RQ1 O +
DNAase O +
( O -
Promega O -
) O +
according O +
to O +
the O +
manufacturer O -
's O +
instructions O -
. O +

One O +
ug O +
of O +
total O +
RNA O +
for O +
each O +
sample O +
was O +
processed O +
using O +
the O +
Affymetrix O +
GeneChip O +
Whole O +
Transcript O +
Sense O +
Target O +
Labeling O +
Assay O +
( O -
Affymetrix O -
) O -
. O +

Ribosomal O +
RNA O +
was O +
reduced O +
with O +
the O +
RiboMinus O +
Kit O +
( O -
Invitrogen O -
) O -
. O +

Target O +
material O +
was O +
prepared O +
using O +
commercially O +
available O +
Affymetrix O +
GeneChip O +
WT O +
cDNA O +
Synthesis O +
Kit O -
, O +
WT O +
cDNA O +
Amplification O +
Kit O -
, O +
and O +
WT O +
Terminal O +
Labeling O +
Kit O +
( O -
Affymetrix O -
) O +
as O +
per O +
manufacturer O -
's O +
instructions O -
. O +

Hybridization O +
cocktails O +
containing O +
∼5 O +
ug O +
of O +
fragmented O +
and O +
labeled O +
DNA O +
target O +
were O +
prepared O +
and O +
applied O +
to O +
GeneChip O +
Human B-Species +
Exon O +
1.0 O +
ST O +
arrays O -
. O +

Hybridization O +
was O +
performed O +
for O +
16 O +
hours O +
using O +
the O +
Fluidics O +
450 O +
station O -
. O +

Arrays O +
were O +
scanned O +
using O +
the O +
Affymetrix O +
3000 O +
7 O -
G O +
scanner O +
and O +
GeneChip O +
Operating O +
Software O +
version O +
1.4 O +
to O +
produce O +
.CEL O +
intensity O +
files O -
. O +

Detection O +
of O +
AS O +
by O +
RT O -
- O -
PCR.cDNAs O +
were O +
generated O +
from O +
total O +
RNA O +
with O +
Superscript O +
III O +
reverse O +
transcriptase O +
( O -
Invitrogen O -
) O -
. O +

PCR O +
reactions O +
were O +
performed O +
with O +
primer O +
pairs O +
designed O +
for O +
AS O +
targets O +
( O -
annealing O +
at O +
58 O +
° O -
C O +
and O +
amplification O +
for O +
30 O +
or O +
35 O +
cycles O -
) O -
. O +

PCR O +
products O +
were O +
resolved O +
on O +
either O +
1.5 O -
% O +
or O +
3 O -
% O +
agarose O +
gel O +
in O +
TBE O -
. O +

The O +
Ethidium O +
Bromide O -
- O -
stained O +
gels O +
were O +
scanned O +
with O +
Typhoon O +
8600 O +
scanner O +
( O -
Molecular O +
Dynamics O -
) O +
for O +
quantification O -
. O +

The O +
number O +
of O +
true O +
positives O +
( O -
TP O -
; O +
false O +
negatives O -
, O +
FN O -
) O +
was O +
computed O +
as O +
the O +
number O +
of O +
REAP O -
[ O -
+ O -
] O +
( O -
REAP O -
[ O -
− O -
] O -
) O +
exons O +
that O +
were O +
validated O +
by O +
RT O -
- O -
PCR O +
as O +
AS O -
. O +

The O +
number O +
of O +
true O +
negatives O +
( O -
TN O -
; O +
or O +
FPs O -
) O +
was O +
computed O +
as O +
the O +
number O +
of O +
REAP O -
[ O -
− O -
] O +
( O -
REAP O -
[ O -
+ O -
] O -
) O +
exons O +
that O +
were O +
validated O +
by O +
RT O -
- O -
PCR O +
as O +
constitutively O +
spliced O -
. O +

The O +
true O +
( O -
false O -
) O +
positive O +
rate O +
was O +
computed O +
as O +
TP O +
( O -
FP O -
) O +
divided O +
by O +
the O +
total O +
number O +
of O +
REAP O -
[ O -
+ O -
] O +
exons O +
in O +
the O +
experimentally O +
validated O +
set O -
. O +

The O +
true O +
( O -
false O -
) O +
negative O +
rate O +
was O +
computed O +
as O +
the O +
TN O +
( O -
FN O -
) O +
divided O +
by O +
the O +
total O +
number O +
of O +
REAP O -
[ O -
− O -
] O +
exons O +
in O +
the O +
experimentally O +
validated O +
set O -
. O +

Sensitivity O +
was O +
computed O +
as O +
TP O -
/ O -
( O -
TP+FN O -
) O +
and O +
specificity O +
was O +
computed O +
as O +
TN O -
/ O -
( O -
FP+TN O -
) O -
. O +

Sequence O +
databases O -
. O +

Genome O +
sequences O +
of O +
human B-Species +
( O -
hg17 O -
) O -
, O +
dog B-Species +
( O -
canFam1 O -
) O -
, O +
rat B-Species +
( O -
rn3 O -
) O -
, O +
and O +
mouse B-Species +
( O -
mm5 O -
) O +
were O +
obtained O +
from O +
UCSC O -
, O +
as O +
were O +
the O +
whole O -
- O -
genome O +
MULTIZ O +
alignments O +
[ O -
80 O -
] O -
. O +

The O +
lists O +
of O +
known O +
human B-Species +
genes O +
( O -
knownGene O +
containing O +
43,401 O +
entries O -
) O +
and O +
known O +
isoforms O +
( O -
knownIsoforms O +
containing O +
43,286 O +
entries O +
in O +
21,397 O +
unique O +
isoform O +
clusters O -
) O +
with O +
annotated O +
exon O +
alignments O +
to O +
human B-Species +
hg17 O +
genomic O +
sequence O +
were O +
processed O +
as O +
follows O -
. O +

Known O +
genes O +
that O +
were O +
mapped O +
to O +
different O +
isoform O +
clusters O +
were O +
discarded O -
. O +

All O +
mRNAs O +
aligned O +
to O +
hg17 O +
that O +
were O +
greater O +
than O +
300 O +
bases O +
long O +
were O +
clustered O +
together O +
with O +
the O +
known O +
isoforms O -
. O +

Genes O +
containing O +
less O +
than O +
three O +
exons O +
were O +
removed O +
from O +
further O +
consideration O -
. O +

A O +
total O +
of O +
2.7 O +
million O +
spliced O +
ESTs O +
were O +
mapped O +
onto O +
the O +
17,478 O +
high O -
- O -
quality O +
genes O +
to O +
infer O +
AS O -
. O +

Exons O +
with O +
canonical O +
splice O +
signals O +
( O -
GT O -
- O -
AG O -
, O +
AT O -
- O -
AC O -
, O +
GC O -
- O -
AG O -
) O +
were O +
retained O -
, O +
resulting O +
in O +
a O +
total O +
of O +
213,736 O +
exons O -
. O +

Of O +
these O -
, O +
197,262 O +
( O -
92 O -
% O +
of O +
all O +
exons O -
) O +
were O +
constitutive O +
exons O -
, O +
13,934 O +
exons O +
( O -
7 O -
% O -
) O +
had O +
evidence O +
of O +
exon O -
- O -
skipping O -
, O +
1,615 O +
( O -
1 O -
% O -
) O +
exons O +
were O +
mutually O +
exclusive O +
alternative O +
events O -
, O +
5,930 O +
( O -
3 O -
% O -
) O +
exons O +
had O +
alternative O +
3′ O +
splice O +
sites O -
, O +
5,181 O +
( O -
2 O -
% O -
) O +
exons O +
had O +
alternative O +
5′ O +
splice O +
sites O -
, O +
and O +
175 O +
( O -
< O -
1 O -
% O -
) O +
exons O +
overlapped O +
another O +
exon O -
, O +
but O +
did O +
not O +
fall O +
into O +
the O +
above O +
classifications O -
. O +

A O +
total O +
of O +
324,139 O +
probesets O +
from O +
the O +
Affymetrix O +
Human B-Species +
Exon O +
1.0 O +
ST O +
array O +
were O +
mapped O +
to O +
208,422 O +
human B-Species +
exons O -
, O +
representing O +
17,431 O +
genes O -
. O +

These O +
probesets O +
were O +
used O +
to O +
derive O +
gene O +
and O +
exon O -
- O -
level O +
signal O +
estimates O +
from O +
the O +
CEL O +
files O -
. O +

The O +
four O -
- O -
way O +
mammalian O +
( O -
four O -
- O -
mammal O -
) O +
whole O -
- O -
genome O +
alignment O +
( O -
hg17 O -
, O +
canFam1 O -
, O +
mm5 O -
, O +
rn3 O -
) O +
was O +
extracted O +
from O +
the O +
eight O -
- O -
way O +
vertebrate O +
MULTIZ O +
alignments O +
( O -
hg17 O -
, O +
panTrol1 O -
, O +
mm5 O -
, O +
rn3 O -
, O +
canFam1 O -
, O +
galGal2 O -
, O +
fr1 O -
, O +
danRer1 O -
) O +
obtained O +
from O +
the O +
UCSC O +
Genome O +
Browser O -
. O +

Four O -
- O -
way O +
mammal O +
alignments O +
were O +
extracted O +
for O +
all O +
internal O +
exons O -
, O +
and O +
400 O +
bases O +
of O +
flanking O +
intronic O +
sequence O -
, O +
resulting O +
in O +
a O +
total O +
of O +
161,731 O +
conserved O +
internal O +
exons O -
. O +

A O +
total O +
of O +
145,613 O +
( O -
90 O -
% O +
of O +
total O -
) O +
conserved O +
internal O +
exons O +
were O +
constitutive O +
exons O -
, O +
13,653 O +
exons O +
( O -
8 O -
% O -
) O +
had O +
evidence O +
of O +
exon O -
- O -
skipping O -
, O +
1,576 O +
exons O +
were O +
mutually O +
exclusive O +
alternative O +
events O -
, O +
5,818 O +
exons O +
had O +
alternative O +
3′ O +
splice O +
sites O -
, O +
5,046 O +
exons O +
had O +
alternative O +
5′ O +
splice O +
sites O -
, O +
and O +
168 O +
exons O +
overlapped O +
another O +
exon O -
. O +

Exon O +
array O +
analysis O -
. O +

The O +
Affymetrix O +
Power O +
Tools O +
( O -
APT O -
) O +
suite O +
of O +
programs O +
was O +
obtained O +
from O +
http://www.affymetrix.com/support/developer/powertools/index.affx O -
. O +

Exon O +
( O -
probeset O -
) O +
and O +
gene O -
- O -
level O +
signal O +
estimates O +
were O +
derived O +
from O +
the O +
CEL O +
files O +
by O +
RMA O -
– O -
sketch O +
normalization O +
as O +
a O +
method O +
in O +
the O +
apt O -
- O -
probeset O -
- O -
summarize O +
program O -
. O +

To O +
determine O +
if O +
the O +
signal O +
intensity O +
for O +
a O +
given O +
probeset O +
is O +
above O +
the O +
expected O +
level O +
of O +
background O +
noise O -
, O +
we O +
utilized O +
the O +
DABG O +
( O -
detection O +
above O +
background O -
) O +
quantification O +
method O +
available O +
in O +
the O +
apt O -
- O -
probeset O -
- O -
summarize O +
program O +
as O +
part O +
of O +
Affymetrix O +
Power O +
Tools O +
( O -
APT O -
) O -
. O +

Briefly O -
, O +
DABG O +
compared O +
the O +
signal O +
for O +
each O +
probe O +
to O +
a O +
background O +
distribution O +
of O +
signals O +
from O +
anti O -
- O -
genomic O +
probes O +
with O +
the O +
same O +
GC O +
content O -
. O +

The O +
DABG O +
algorithm O +
generated O +
a O +
p O -
- O -
value O +
representing O +
the O +
probability O +
that O +
the O +
signal O +
intensity O +
of O +
a O +
given O +
probe O +
was O +
part O +
of O +
the O +
background O +
distribution O -
. O +

We O +
considered O +
a O +
probeset O +
with O +
a O +
DABG O +
p O -
- O -
value O +
lower O +
than O +
0.05 O +
as O +
detected O +
above O +
background O -
. O +

The O +
statistic O +
thCNS O -
- O -
SCns O -
, O -
ESC O +
= O +
( O -
μhCNS O -
- O -
SCns O +
− O +
μESC O -
) O +
/ O +
sqrt O +
( O -
( O -
( O -
nhCNS O -
- O -
SCns O +
− O +
1 O -
) O -
σ2hCNS O -
- O -
SCns O +
+ O +
( O -
nESC O +
− O +
1 O -
) O -
σ2ESC O -
) O -
( O -
nhCNS O -
- O -
SCns O +
+ O +
nESC O -
) O -
) O +
/ O +
( O -
( O -
nhCNS O -
- O -
SCnsnESC O -
) O +
( O -
nhCNS O -
- O -
SCns O +
+ O +
nESC O +
− O +
2 O -
) O -
) O -
) O -
, O +
where O +
nhCNS O -
- O -
SCns O +
and O +
nESC O +
were O +
the O +
number O +
of O +
replicates O -
, O +
μhCNS O -
- O -
SCns O +
and O +
μESC O +
were O +
the O +
mean O -
, O +
and O +
σ2hCNS O -
- O -
SCns O +
and O +
σ2ESC O +
were O +
the O +
variances O +
of O +
the O +
expression O +
values O +
for O +
the O +
two O +
datasets O +
used O +
to O +
represent O +
the O +
differential O +
enrichment O +
of O +
a O +
gene O +
using O +
gene O -
- O -
level O +
estimates O +
in O +
hCNS O -
- O -
SCns O +
relative O +
to O +
hESCs O -
. O +

Multiple O +
hypothesis O +
testing O +
was O +
corrected O +
by O +
controlling O +
for O +
the O +
false O +
discovery O +
rate O +
( O -
Benjamini O -
- O -
Hochberg O -
) O -
. O +

AS O +
detection O +
by O +
REAP.The O +
log2 O +
signal O +
estimate O +
xij O +
for O +
probeset O +
i O +
in O +
cell O -
- O -
type O +
j O +
had O +
to O +
satisfy O +
two O +
conditions O -
, O +
otherwise O +
the O +
probeset O +
was O +
discarded O -
: O +
( O -
i O -
) O +
2 O +
< O +
xij O +
< O +
10,000 O +
for O +
all O +
conditions O -
/ O -
cell O -
- O -
types O +
j O -
; O +
and O +
( O -
ii O -
) O +
DABG O +
p O -
- O -
value O +
< O +
0.05 O +
for O +
all O +
replicates O +
in O +
at O +
least O +
one O +
condition O -
/ O -
cell O -
- O -
type O +
j. O +
A O +
gene O +
had O +
to O +
have O +
five O +
probesets O +
that O +
satisfied O +
the O +
two O +
conditions O +
above O +
in O +
order O +
to O +
be O +
considered O +
for O +
robust O +
regression O +
analysis O -
. O +

After O +
generating O +
the O +
points O +
( O -
as O +
described O +
in O +
the O +
Results O +
section O -
) O -
, O +
we O +
utilized O +
the O +
robust O +
regression O +
method O +
rlm O +
in O +
R O -
- O -
package O +
" O -
MASS O -
" O +
( O -
version O +
6.1–2 O -
) O +
with O +
M O -
- O -
estimation O +
and O +
a O +
maximum O +
iteration O +
setting O +
of O +
30 O +
to O +
estimate O +
the O +
linear O +
function O +
yi O +
= O +
αxi O +
+ O +
β O -
. O +

For O +
each O +
probeset O -
, O +
we O +
computed O +
the O +
error O +
term O +
ei O -
, O -
, O +
which O +
was O +
the O +
difference O +
between O +
the O +
actual O +
value O +
yi O +
and O +
the O +
estimated O +
value O +
ξi O -
, O +
from O +
the O +
estimated O +
function O +
ξi O +
= O +
Axi O +
+ O +
B O -
, O +
where O +
A O +
and O +
B O +
were O +
estimates O +
of O +
α O +
and O +
β O -
. O +

The O +
error O +
term O +
variance O +
was O +
estimated O +
by O +
se2 O +
= O +
Σei2 O -
/ O -
( O -
n O +
− O +
p O -
) O -
, O +
which O +
was O +
used O +
to O +
estimate O +
the O +
variance O +
of O +
the O +
predicted O +
value O -
, O +
sξi2 O +
= O +
se2 O -
( O -
n−1 O +
+ O +
( O -
xi O +
− O +
μx O -
) O -
2 O +
/ O +
sx2 O -
( O -
n O +
− O +
1 O -
) O -
) O -
. O +

Here O -
, O +
n O +
referred O +
to O +
the O +
number O +
of O +
points O +
( O -
generated O +
for O +
each O +
gene O -
) O -
, O +
and O +
p O +
referred O +
to O +
the O +
number O +
of O +
independent O +
variables O +
( O -
p O +
= O +
2 O +
in O +
our O +
method O -
) O -
; O +
and O +
μx O +
= O +
Σxi2 O -
/ O -
n O -
; O +
sx2 O +
= O +
n−1 O +
Σ O -
( O -
xi O +
− O +
μx O -
) O -
2 O -
. O +

Following O +
Belsley O +
et O +
al. O +
[ O -
81 O -
] O -
, O +
we O +
defined O +
the O +
leverage O +
hi O +
of O +
the O +
ith O +
point O +
as O +
hi O +
= O +
n−1 O +
+ O +
( O -
xi O +
− O +
μx O -
) O -
2 O +
/ O +
sx2 O -
( O -
n O +
− O +
1 O -
) O -
. O +

Here O +
we O +
considered O +
a O +
point O +
to O +
have O +
high O +
leverage O +
if O +
hi O +
> O +
3p O -
/ O -
n O -
. O +

Next O -
, O +
we O +
calculated O +
the O +
covariance O +
ratio O -
, O +
covi O +
= O +
( O -
si2 O -
/ O -
sr2 O -
) O -
p O -
/ O -
( O -
1 O +
− O +
hi O -
) O -
, O +
which O +
is O +
the O +
ratio O +
of O +
the O +
determinant O +
of O +
the O +
covariance O +
matrix O +
after O +
deleting O +
the O +
ith O +
observation O +
to O +
the O +
determinant O +
of O +
the O +
covariance O +
matrix O +
with O +
the O +
entire O +
sample O -
. O +

We O +
considered O +
a O +
point O +
to O +
have O +
high O +
influence O +
if O +
|covi O +
− O +
1| O +
> O +
3p O -
/ O -
n O -
. O +

Lastly O -
, O +
we O +
computed O +
the O +
studentized O +
residuals O -
, O +
rstudenti O +
= O +
ei O +
/ O +
( O -
s O -
( O -
i O -
) O -
2 O +
( O -
1 O +
− O +
hi O -
) O -
0.5 O -
) O -
, O +
where O +
s O -
( O -
i O -
) O -
2 O +
= O +
( O -
n O -
- O -
p O -
) O -
se2 O +
/ O +
( O -
n O -
- O -
p-1 O -
) O +
– O +
ei2 O +
/ O +
( O -
n O -
- O -
p-1 O -
) O -
( O -
1 O +
− O +
hi O -
) O -
, O +
the O +
error O +
term O +
variance O +
after O +
deleting O +
the O +
ith O +
point O -
. O +

As O +
rstudenti O +
was O +
distributed O +
as O +
Student O -
's O +
t O -
- O -
distribution O +
with O +
n O -
- O -
p-1 O +
degrees O +
of O +
freedom O -
, O +
each O +
rstudenti O +
value O +
was O +
associated O +
with O +
a O +
p O -
- O -
value O -
. O +

We O +
considered O +
a O +
point O +
to O +
be O +
an O +
" O -
outlier O -
" O +
if O +
p O +
< O +
0.01 O -
. O +

Identification O +
of O +
motifs O -
. O +

The O +
enrichment O +
score O +
of O +
a O +
sequence O +
element O +
of O +
length O +
k O +
( O -
k O -
- O -
mer O -
) O +
in O +
one O +
set O +
of O +
sequences O +
( O -
set O +
1 O -
) O +
versus O +
another O +
set O +
of O +
sequences O +
( O -
set O +
2 O -
) O +
was O +
represented O +
by O +
the O +
nonparametric O +
χ2 O +
statistic O +
with O +
Yates O +
correction O -
, O +
computed O +
from O +
the O +
two O +
by O +
two O +
contingency O +
table O -
, O +
T O +
( O -
T11 O -
: O +
number O +
of O +
occurrences O +
of O +
the O +
element O +
in O +
set O +
1 O -
; O +
T12 O -
: O +
number O +
of O +
occurrences O +
of O +
all O +
other O +
elements O +
of O +
similar O +
length O +
in O +
set O +
1 O -
; O +
T21 O -
: O +
number O +
of O +
occurrences O +
of O +
element O +
in O +
set O +
2 O -
; O +
T22 O -
: O +
number O +
of O +
occurrences O +
of O +
all O +
other O +
elements O +
of O +
similar O +
length O +
in O +
set O +
2 O -
. O +

All O +
elements O +
had O +
to O +
be O +
greater O +
than O +
5 O -
. O +

To O +
correct O +
for O +
multiple O +
hypothesis O +
testing O -
, O +
p O -
- O -
values O +
were O +
multiplied O +
by O +
the O +
total O +
number O +
of O +
comparisons O -
. O +

